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    Since the beginning of catalytic asymmetric hydroboration (CAHB) in 1989, many 
new approaches have been developed.   Developing an efficient method of catalytic 
asymmetric hydroboration to produce useful chiral organoboranes is still a challenge due 
to limited success with a small range of substrates.   Typically, effective CAHB requires 
the presence of vinylarene moiety or a particular substitution pattern around the alkene. 
One area of research in the Takacs group has been to expand this substrate scope by 
incorporating two-point binding to direct the reaction to one regioisomer selectively.  
CAHB of two-point binding substrates in the presence of simple chiral monophosphite 
and monophosphoramidite ligands is an attractive approach to overcome this challenge.  
    One of the long standing challenges is the catalytic asymmetric hydroboration of 1,1-
disubstituted alkenes.  Although practical and highly enantioselective conjugate addition 
and hydroboration utilizing stoichiometric amounts of chiral borane of 1,1-disubtituted 
alkenes by Hoveyda , Mazet, and Soderquist have been demonstrated, CAHB of 1,1 
disubstituted alkenes remain a significant challenge.   Herein, we report an elegant 
solution of this problem using two-point binding.  For example, this reaction can be 
 carried out by treatment of the β,γ-disubstituted alkene unsaturated amide with 
Rh(nbd)2BF4 and ligands TADDOL-derived monophosphite or BINOL-derived 
monophosphoramidite. High catalytic activity (62%), high regioselectivity (> 96%), and 
enantioselectivities up to 94% were obtained with the β,γ-unsaturated ester  framework. 
The applicability of this method was further highlighted by successfully forming chiral β 
-substituted butyrolactones, the key precursor for the synthesis of biologically active 
natural products including lignans.  This method also enables for the efficient preparation 
of trifluoroborate salts to provide chiral reagents for the Suzuki- Miyaura cross coupling 
reaction.
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Chapter 1- Introduction 
1.2 Development of asymmetric synthesis  
Asymmetric synthesis is a fundamental technology for producing enantiomerically 
pure materials which play a particularly important role in science and industry.1 For 
example, proxyphene has two enantiomers and each one has a different biological 
activity2 (Figure 1).  , Darvon has an analgesic property while Novrad has an 
antitussive property. 
 
 
Figure1. Two Enantiomers of Proxyphene 
 
A small amount of chiral, enantiomerically pure catalyst can, in principle, effectively 
promote reactions and lead to the formation of large amounts of enantiomerically pure 
compounds.  Some of these products may be very difficult to form by any other 
accessible method. Intensive research efforts have been devoted to the development of 
selective and practical asymmetric catalytic protocols and a large variety of chiral ligands 
and catalytic systems have been developed for asymmetric reactions in industry and 
academia.3   
Catalytic chiral reactions such as hydrogenation,1oxidation,3 and alkylation3 have been 
developed to the point that they are used routinely on an industrial scale. 
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William S. Knowles4 in 1968 pioneered methods in enantioselective synthesis by 
replacing the achiral triphenylphosphine ligands in Wilkinson's catalyst with the chiral 
phosphine ligands. i.e.,  (Ph)P(Me)Pr, and employed this modified catalyst in asymmetric 
hydrogenation reactions. This experiment gave only a modest level of asymmetric 
induction (15% enantiomeric excess (ee)) but set the stage for the field to rapidly 
advance. Further research into the nature of the chiral ligand led to DIPAMP. This latter 
method of creating asymmetric compounds has been effectively utilized in the 
hydrogenation step of the industrial production of L-DOPA. This discovery of 
accelerating production of L-DOPA was one among the first economical and efficient 
method to generate chiral compounds by asymmetric catalysis using chemical catalysts.5 
The continued growth of asymmetric catalysis have been advanced with the use of recent 
techniques such as high-throughput screening and computational studies.3,6 
 
 
 
Figure 2. Enantioselective Hydrogenation Step in the Industrial Production of L-DOPA. 
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The Takacs group has been among the leaders in developing directed catalytic 
asymmetric hydroboration (CAHB) reactions for the preparation of chiral organoboranes. 
The reaction bears some similarity to catalytic asymmetric hydrogenation as will be seen 
in this dissertation. 
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1.2 The Versatility of organoboranes 
    Hydroboration reactions are one of the most important processes to produce 
organoboronates from alkenes (C=C and C-C triple bonds under readily accessible 
conditions.7 This reaction involves the addition of hydrogen and a boron atom across the 
Π- system of a double or triple bond.  It has gained considerable attention because it 
possesses unique properties such as proceeding under much milder conditions to produce 
synthetic intermediates such as organoboronates that can be easily converted into 
secondary products with wide range of functional groups.8,9,10 (Figure 3). 
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Figure 3. Functional Group Transformations of Chiral Organoboronate Intermediates 
     
Many protocols that utilize chiral organoboronates reactions have emerged. For example, 
Molander11 reported the stereospecific Suzuki-Miyaura cross coupling of enantio-
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enriched alkyltrifluoroborates (10 mol % of Pd(OAc)2 and 20 mol % of XPhos). 
Interestingly, this reaction was shown to be very efficient with a variety of substrates and 
gives the product with complete inversion of configuration. Crudden also provided 
successful example of cross-coupling using chiral secondary boronic esters and palladium 
to regioselectively form product with retention of enantioselectivity (0.15 mmol of Ag2O, 
8% Pd2(dba)3, 8-12 equiv of PPh3) (Figure 4).12 
 
 
Figure 4. Carbon-Carbon Cross Coupling using Chiral Secondary Boronic Esters 
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The recent synthetic utility of boronate esters are summarized in (Figure 5).13, 14, 15, 16 
 
 
Figure 5.  Representative Examples of Synthetic Reactions of Boronate Ester  
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1.3 Background of transition metal catalyzed hydroboration 
 
Männig and Nöth’s in 1985 reported the first catalytic hydroboration reaction using 
tris(triphenylphosphine)chlororhodium (I) (Wilkinson’s catalyst to catalyze the addition 
of catecholborane (CatBH) across a double bond.17This led to a rapid increase in interest 
toward developing a highly efficient catalytic process for the synthesis of enantiopure 
organoboronates via transition metal-catalyzed reactions with high levels of regio- and 
stereochemical control. There can be significant differences in reactivity between 
catalyzed and non-catalyzed reactions of the same substrate. For instance, metal-
catalyzed hydroboration of unsaturated ketones in the presence of 1 mol % of 
RhCl(PPh3)3 led to the product resulting from the addition of  catecholborane to the 
double bond whereas the hydroboration by catecholborane without the catalyst led to the 
addition of catecholborane to the carbonyl group. The difference between catalyzed and 
non-catalyzed reactions is also seen in hydroboration of styrene. Catalyzed hydroboration 
favors the Markovnikov addition products (after C-B bond oxidation) while the non-
catalyzed reaction produces the anti-Markovnikov addition product (Figure 6). 
Figure 6.  Rh( I)-Catalyzed/ non-Catalyzed Hydroboration Reaction using 
Catecholborane (CatBH). 
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Suzuki18and Burgess19 studied the control of regioselectivity and diastereoselectivity of 
the catalyzed and non-catalyzed hydroborations of allylic compounds. In 1988, the 
Burgess group reported the first example of a catalytic asymmetric hydroboration 
(CAHB) reaction. They subjected 1,2-disubstituted olefins, for example norbornene, to 
catalytic hydroboration conditions by CatBH using ([Rh(cod)Cl]2 and the chiral 
diphosphine, (R,R)-DIOP. The reactions proceed smoothly to furnish norbornol (90%, 
64% ee). Suzuki employed Rh(I) in combination with (S,S)-DIOP with indene and also 
obtained moderate enantioselectivity in the CAHB (91%, 74 % ee) (Figure 7). 
 
 
Figure 7.   Early Enantioselective Hydroboration using Rhodium–Ligand Catalyst 
Combinations. 
The synthetic potential of CAHB was quickly realized,  and a big step forward was made 
by Hayashi and coworkers;20 they demonstrated the switching of regioselectivity using a 
cationic phosphine-rhodium catalyst Rh(I) for the hydroboration of styrene derivatives to 
produce secondary benzylic boranes with high enantioselectivity (Figure 8). 
9 
 
 
 
Figure 8. CAHB with Chiral Catalysts by Hayashi and Coworkers. 
 
1.4 Directed hydroboration  
The development of directed catalytic hydroboration was initiated in 1980s. Evans found 
that the amide group can serve as a directing group with the best selectivity found using 
Crabtree’s iridium catalyst, although practical levels were found with rhodium, too. Both 
cyclic and acyclic substrates have been shown the proximal addition of boron 
demonstrating the directing ability of the amide group.22 Moreover; they achieved 
excellent diastereoselectivity with phosphite –directed hydroboration in combination of 
rhodium complexes. The reaction proceeds successfully in presence of stoichiometric 
amounts of Wilkinson’s catalyst and catecholborane followed by oxidative workup by 
basic hydrogen peroxide to cleave the phosphites. Although Evans carried out the 
pioneering work in directed catalytic asymmetric hydroboration, Fu later presented an 
efficient hydroboration by employing an indenyl ligand to provide coordinative saturation 
around the metal which is required for binding with the alkene moiety.23With this system, 
high levels of selectivity were obtained indicative of an ether-directed reaction (75%) 
(Figure 9). 
10 
 
 
 
 
Figure 9.Examples of Directed Hydroboration 
 
A further development of this chemistry was reported by Gevorgyan, et al;24 who used a 
pendant ester as a highly efficient directing functional group; esters provide a versatile 
functional group which can be used for further transformations.  He employed 
[Rh(COD)Cl]2 and pinacolborane to the 3,3-disubstituted cyclopropenes. The reaction 
proceeded effectively to furnish >99:1 cis-diastereoselectivity in excellent 
enantioselectivity up to 99 % ee .Vedejs25 recently discussed the efficiency of amine in 
the non-catalyzed directed hydroboration of a β,γ-unsaturated amine by THF·BH3 
11 
 
 
followed by oxidative workup. The latter substrates exhibit 43:1 regioselectivity in favor 
of the 3,5-disubstituted product (Figure 10). 
 
Figure 10.Representative Functional Groups Directed Hydroboration. 
1.5 Hydroboration reagents 
A number of boranes have been prepared and employed for the non-catalyzed 
hydroboration of a wide variety of cyclic and acyclic substrates. In contrast, CatBH and 
pinacolborane (pinBH) are by far the most popular boranes used in the catalyzed 
reaction; a wide range of transition metal complexes have been explored, too. Other 
reagents were also employed in catalytic hydroboration with variable success.26  For 
research described later in this dissertation, it should be noted that Kono et al.27 reported 
4,4,6-trimethyl-1,3,2-dioxyborinane (TMDB) undergoes in the oxidative addition with 
Wilkinson’s catalyst (Figure 11). Woods and Strong also used this borane for the non-
12 
 
 
catalyzed hydroboration reaction of many alkenes,28 and Evans used it in his original 
report of the catalyzed reaction.  
 
Figure 11. Oxidative Addition of TMDB with Wilkinson’s Catalyst 
The choice of borane employed in a hydroboration reaction can have a significant 
influence on the mechanism and regioselectivity of the catalyzed reaction.  For instance, 
the reaction of perfluroroalkylethylenes with CatBH catalyzed by (DPPB)Rh(I) gives the 
internal secondary borane with very high regioselectivity and furnishes the secondary 
alcohol after oxidative workup.  Employing pinBH with RhCl(PPh3)3, the reaction forms 
the primary borane and, following the oxidative workup, the primary alcohol.29 Another 
example which highlights the important role of the borane in the selectivity of catalytic 
systems is in the hydroboration of 4-octene. When CatBH is used in combination with 
Wilkinson’s catalyst, the reaction gives the secondary alcohol in very high selectivity; in 
contrast, pinBH in the reaction proceeds with apparent alkene isomerization to give the 
primary alcohol after oxidative workup (Figure 12).30 
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Figure 12. Regiochemical Reversal with Catecholborane and Pinacolborane 
1.6 Enantioselective hydroborations 
The enantioselective construction of chiral molecules is an important issue because many 
natural compounds have chiral centers.1 Since the pioneering work of Männig and Nöth, 
much effort has been directed toward creating enantiomerically enriched stereocenters 
with boron as a substituent. As discussed above, modest levels of enantioselectivity were 
reported by Burgess and Suzuki for the CAHB of l,l- and 1,2-disubstituted olefins. 
Hayashi et.al, reported the significant contribution to catalytic enantioselective 
hydroboration,20 they also establish several new and broadly applicable improvements 
including modifications of the ligand and catalyst in the enantioselective process.  This 
reaction is performed with a cationic rhodium catalyst combined with (+)-2,2'-
bis(diphenyIphosphino)- l,l'-binaphthyl (BINAP). The cationic rhodium/BINAP complex 
was highly active. For instance, the hydroboration reaction of styrene proceeds to 
completion in 30 min even at -30 oC with 1 mol % of the catalyst.  
14 
 
 
The successes of employing BINAP as a chiral ligand in a variety substrates 
demonstrates that the BINAP is one of the best ligands in enantioselective hydroboration 
reactions. However, even its scope for CAHB is rather limited. In the case of styrene 
substrates, electron rich olefins give higher enantioselective than the electron poor 
substrates. The sterically hindered substrate like ortho-substituted styrenes shows low 
yield and low enantioselectivity. α or β-substitution of the double bond generally lead to 
low enantioselectivities with this particular ligand (Figure 13). Nonetheless, 
diphsophanes are, by far, the most extensively used class of ligands; they show a wide 
range of reactivity and enantioselectivity.1 Some of the more successful examples are 
discussed in the following paragraph. 
Figure 13.Hydroboration of Styrene with Rhodium Combined with BINAP Ligand. 
Knochel31 reported preparation of the dicyclohexylbis(phosphane), shown in Figure 14, 
and reported that it gave high chemo-, regio- and enantioselectivity in the rhodium-
catalyzed hydroboration with CatBH.  He employed this system on a number of para-, 
meta- and ortho-styrenes to furnish a range of enantioselectivity (76-93 %) with one 
exception (p-CF3, 58 % ee). Buono reported that the bis(aminophosphane) gives results 
within the range of (42-77 % ee) in styrene system.32 The accumulated results of ligand 
screenings suggest that changing the ligand backbone has a profound effect on the yield, 
regioselectivity and enantioselectivity of these reactions (Figure 14). 
15 
 
 
 
Figure 14.  Recent Rhodium-Catalyzed CAHBs with Chelating P,P-Ligands.1  
The Takacs group34 studied the CAHB reaction of styrene and styrene derivatives using 
effective TADDOL-derived monodentate ligands such as phosphite LA and 
phosphoramidite LB. These ligands furnish highly enantioselective products in 
combination with a Rh(nbd)Cl derived catalyst. Many of the styrene derivatives were 
examined with pinBH and CatBH for comparison purposes.  Introducing electron 
donating group such as -OMe at para position in styrene produced (96%, 93% ee) with 
ligand LA and (96%, 94% ee) with ligand LB. A strong inductive electron withdrawing 
group (e.g., CF3) in the same position produced (96%, 90% ee) with ligand LA and (92%, 
90%ee) with ligand LB (Figure 15).  
Related TADDOL-derived ligands and BINOL-derived phosphoramidites are also useful 
with substrates that exploit the directing ability of amide functional group to promote the 
CAHB with two point binding between olefin moiety and the amide to rhodium as a 
model to explain their effectiveness.35  CAHB of β,γ-unsaturated Weinreb amides are 
16 
 
 
another directing group studied by the Takacs group.36 The Weinreb amides add synthetic 
value since they readily undergo transformation to other functional groups. For example, 
the Weinreb amide shown furnishes the β-hydroxy acid after the oxidative workup of the 
product of TMDB addition using Rh(nbd)2BF4 in conjunction with phosphoramidite L1 
(77%, 92% ee) (Figure 15). 
 
Figure 15. Highly Enantioselective CAHB with Chiral Monodentate Ligands Reported 
from the Takacs Group. 
1.7 Mechanism of rhodium-catalyzed hydroboration 
The key to achieving a successful hydroboration reaction is developing an efficient and 
useful method to produce a boronate ester with a high degree of regio-, diastereo-, and/or 
enantioselectivity by applying chiral ligands to introduce the enantioselectivity in the 
17 
 
 
outcome.  Experimentally, it has been found that the reaction is sensitive to many 
different factors, including the catalyst nature, borane reagents, solvents, temperature, 
and the interplay between steric and electronic effects on the substrate. 
Männing and Nöth carried out an investigation to provide experimental evidence. They 
proposed the first generally accepted mechanism of the rhodium-catalyzed hydroboration 
as shown in Figure 16. This model was established on the basis of the observations of the 
reaction between catecholborane with Wilkinson’s catalyst and it is supported by 
deuterium studies in case of vinylboronates and alkane formation37 as well as by 
Ziegler’s38density functional theory calculations.   
The reaction pathway is a dissociative mechanism involving rhodium (I) oxidatively 
adding the B-H bond of catecholborane, followed by alkene coordination with 
simultaneous dissociation of an additional PPh3 group. Migratory insertion of the alkene 
into the Rh-H bond with a subsequent reductive elimination of the alkylboronate ester 
completes the catalytic cycle (Figure 16). 
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Figure 16.  Proposed Rhodium Metal Catalyzed Hydroboration of Vinyl Arene. 
 
In deuterium labeling studies, Evans37,39 found that CatBD (deuterated catecholborane) 
behaved differently with different substrates in reactions catalyzed by RhCl(PPh3)3. The 
two key substrates were styrene and 1-decene. Remarkably, the reactions with styrene 
proceed to complete conversion to form 1-phenyl-2-deuterioethanol without any hydride 
migration or deuterium scrambling that would indicate reversible reaction. The observed 
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deuterium distribution was much different upon the rhodium-catalyzed addition of CatBD 
to 1-decene under the same conditions. Evans suggested that the mechanism is reversible 
from rhodium alkyl complex back to the alkene. The considerable amount of deuterium 
on the terminal carbon in both substrates furthermore suggests that the regio-determining 
step in the catalytic cycle is the selective reductive elimination from the primary alkyl 
rhodium complex (Figure 17). 
 
 
 
Figure  17. Deuterium Labeled Mechanistic Studies using Catecholborane. 
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1.8 Conclusion  
As we have seen, catalytic asymmetric hydroboration (CAHB) is valuable method for the 
synthesis of enantiomerically organoboronate compounds. However, the ability of prior 
technology to reliably produce defined classes of enantiopure products in a predictable 
manner is limited in 1,2-disubstituted and monosubstituted alkenes (vinyl arenes)  using 
catalysts employing more complex, chelating ligands. 
The thesis goal is to expand and develop the generality of directed CAHB of alkenes by 
focusing on the directed CAHB of two-point binding substrates in the β,γ-unsaturated 
carbonyls framework. The use of catalysts derived from simple, readily accessible 
monophosphite and monophosphoramidite ligands demonstrating high efficiency in 
stereochemical control of the reaction and to obtain high enantiopure products will be 
seen in this dissertation. 
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Chapter 2: Carbonyl-directed Catalytic Asymmetric Hydroboration (CAHB) of 1,1-
disubstituted alkenes 
2.1 Background: Amide directing hydroboration of β,γ-disubstituted alkene.  
Catalytic asymmetric hydroboration (CAHB) is potentially a powerful tool for 
preparation of chiral organoborane molecules. Advantages of organoborane reagents 
include the numerous reactions than can be used to convert organoboranes to useful 
organic substructures and the ease with which their properties can be tuned.40 Evans and 
co-workers22 elegantly demonstrated the efficiency of the amide moiety in accelerating 
and directing the regiochemical course of catalyzed hydroboration reactions. It is 
noteworthy that the hydroborations of acyclic β,γ-unsaturated amides proceed to give 
highly regioselective results, supporting a two point binding model for these substrates. 
For example, the catalytic hydroboration reaction of β,γ-unsaturated amide X10 followed 
by oxidative work up forms the β-hydroxyamide (74%) with high yield; the 
regioselectivity favoring the oxidation at the β- rather than γ-position is reported to be 
20:1 (Scheme 1). 
 
 
Scheme 1   Amide-directed rhodium-catalyzed hydroboration by evans et. al. 
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The Takacs group in 200835 reported an efficient procedure for amide directed CAHB by 
pinacol borane (pinBH) demonstrating that two-point binding substrates can undergo 
reaction with high enantioselectively using Rh(I) complexes of several chiral 
monodentate phosphorus ligands derived from simple chiral diols such as TADDOL and 
BINOL. For example, CAHB of X11 (R1 = isopropyl) using L1 proceeds in good yield 
(79%) and high enantioselectivity (97% ee).the effectiveness of the chiral ligands 
highlighted by structure L2 varies for different substrates, giving a range of 
enantioselectivity (93-99%). The CAHB also proceeds with high regioselectivity; only 3-
4% of the γ-isomer is formed under the described conditions for each substrate shown 
below in Scheme 2. 
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Scheme 2   Efficient directed CAHB of β,γ-unsaturated amides by takacs et al. 
 
The Takacs group41 provided, as previously mentioned, a new catalyst for the 
hydroboration reaction of β,γ–disubstituted unsaturated phenyl amides. This catalyst 
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proved to be effective for many of the previously problematic cases, and generally 
allowed the reactions to proceed under mild conditions. Based on these findings the 
highly selective CAHB reactions in trisubstituted alkenes were also successfully 
developed. The combination of Rh(nbd)2BF4 with simple TADDOL derived phenyl 
monophosphite ligands in presence of pinBH furnished  products in high enantiopurity as 
shown below in Scheme 3. 
 
Ligand RE RZ Yield % ee% 
L2d (CH2)3Ph CH3 81 95 
L2a CH3 (CH2)3Ph 83 95 
L2d (CH2)4Ph CH3 79 93 
L2c (CH2)2CH3 CH3 80 96 
L2d CH3 CH2CH(CH3)2 81 91 
L2c CH3 CH(CH3)2 80 95 
 
Scheme 3   Amide directed catalytic hydroboration of trisubstituted alkenes by takacs, et 
al.   
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2.2   Previous Attempts of Enantioselective Hydroboration of 1,1-Disubstituted 
Alkenes 
Building on the work of Evans and Takacs, we proposed to expand the scope of 
substrates for directed CAHB to include γ,β-unsaturated amide substrates contained 1,1-
disubstituted alkene moities. The previous studies in the directed CAHB are described in 
the context of (E) - and (Z)-1,2-disubstituted and 1,2,2-trisubstituted alkenes.  There are a 
few examples of the non-directed CAHB of 1,1-disubstituted alkenes. Hoveyda42,43 
reported the net non-directed CAHB of 1,1-disubstituted vinylarene substrates using 
chiral Cu-based bidentate N-heterocyclic carbene (NHC) complexes with 
bis(pinacolato)diboron. Although this study demonstrates that 1,1-disubstituted alkenes 
readily react with CAHB with high enantioselectivity and regioselectivity, only selected 
vinylarenes are successful, and it requires the use of bis(pinacolato)diboron. In particular, 
the successful substrates require a large size difference between the alkene substituents 
(Scheme 4). 
 
  
 
Scheme 4    NHC/Cu-catalyzed CAHB by hoveyda et al. 
 
Significant progress has been made recently in the design and development protocol for 
CAHB of 1,1-disubstituted alkenes by Mazet et al.44 Highly selective and highly efficient 
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iridium catalysts were found to be effective for the CAHB of 1-methylstyrene by pinBH. 
For example, using ligand LL, iridium-catalyzed CAHB gives the terminal product with 
high regio- and enantioselectivity (92%, 92% ee).The versatile chiral organoborane 
product proved useful for subsequent Suzuki cross-coupling reactions (Scheme 5). 
 
 
Scheme 5  Iridium-catalyzed CAHB of α-methylstyrene by Mazet et al. 
 
Soderquist and coworkers developed a useful stoichiometric reagent for the asymmetric 
hydroboration of 1,1-disubstituted alkenes.45 Their chiral 9-borabicyclononane derivative 
exhibited remarkable enantioselectivity for 2-tert-butylpropene, and good selectivity for 
other methylidene substrates, for example, α-methylstyrene shown below (Scheme 6). 
 
 
Scheme 6  Example of stoichiometric asymmetric hydroboration of by Soderquist et al.  
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2.3 Investigation of CAHB of 1,1-disubstituted Alkenes contained a β, γ-unsaturated 
carbonyl framework.  
We began by examining the possibility of using simple 1,1-disubstituted alkenes 
contained within a β,γ-unsaturated carbonyl framework to generate enantiomerically pure 
organoboranes starting with the substrate that contains the methyl substituent in β-
position.  Our protocol (described in detail below) seeks to reduce the number of 
potential catalysts and ligands screened by taking into account the prior art (i.e., 
successful catalyst precursors and chiral ligands) available in the group. Based on our 
own precedents, we can compare results to expectations and we modify the system 
according to prior trends saving time and effort. We had established that simple 
TADDOL-derived phosphite and phosphoramidite ligands afford high levels of 
enantioselectivity in the rhodium-catalyzed asymmetric hydroborations of acyclic β,γ-
unsaturated amides with pinacolborane (pinBH). A BINOL-derived 
monophosphoramidite was also shown to be among the most successful ligands for these 
substrates. The initial investigations employ Rh(nbd)2BF4 since prior studies have shown 
that a readily dissociable counterion is essential. As in prior studies, this investigation 
used both pinBH (vide infra) and 4,4,6-trimethyl-1,3,2-dioxaborinane (TMDB) to screen 
the CAHB of 3-methyl-3-butenoic acid phenyl amide X16 as shown in Table 1 for 
CAHB by TMDB. 
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Table 1  Catalytic hydroboration of 3-methyl-3-butenoic acid phenyl amide X16 with 
TMDB 
 
 
Ligand % yield % ee 
L2b 40 88 
L2c 62 84 
L2d 60 80 
L2a 81 94 
L1 80 63 
L3a 72 -10 
* % Yield and % ee are of the γ-hydroxyamide isomer 
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Amide X16 was screened in the CAHB by TMDB with a series of TADDOL-derived 
ligands to determine their influence on yield, regioselectivity and enantioselectivity. The 
overall highest level of enantioselectivity was obtained from the CAHB of X16 by 
TMDB using Rh(nbd)2BF4 in combination with L2a. CAHB of X16 under those 
conditions affords γ-dioxaborato amide X(16)-1 in moderate yield but excellent 
enantiomeric purity (60%, 94% ee). CAHB of the substrate with ligand L2b affords the γ-
dioxaborato amide X(16)-1 in very good levels of enantiomeric purity (88% ee, Table 1). 
CAHB of the same substrate with other TADDOL-derived ligands, that is, L2c and L2d, 
also afford the respective γ-dioxaborato amide in similarly good levels of enantiomeric 
purity (80-84% ee, entries 3 and 2, respectively). However, directed CAHB of the same 
substrate using phosphoramidite ligand L3a (and some related ligands, data not included 
in Table 1) results in very low enantioselectivity, although the yield is quite reasonable 
(72%, 10% ee). The BINOL-derived monophosphoramidite ligand L1 gave moderate 
levels of enantioselectivity (80%, 63% ee).  
Encouraged by the results obtained with arguably the simplest methylidene substrate 
X16, we continued our investigation into more highly substituted ones, focusing on the 
interplay of alkene and the catalyst as it influences the yield and enantioselectivity. Table 
2 gives a quick view of the major screening results from the CAHB of X17 by TMDB 
and highlights the levels of asymmetric inductions obtained from the screening. Not 
surprisingly, the results of directed CAHB of X17 are similar to those obtained with X16. 
The reaction proceeded smoothly to selectively form the γ-dioxaborato amides in 
enantioselectivities up to 90% ee.   
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Table 2  Catalytic hydroboration of 3-methylidene-pentanoic acid phenyl amide X17 
with TMDB 
 
Ligand % yield  % ee 
L2a 70  90 
L2c 55  83 
L2d 50  71 
L1 52  58 
   
We have developed a highly efficient coordinative catalytic system. One of the major 
advantages of this catalyst system is the general applicability to multiple 1,1-disubstituted 
alkenes. In order to explore the stereochemistry and the regiochemistry of the other 
substituents, we employed the same catalytic system in X18 which has the isobutyl 
substituents in the β-position. Interestingly these experiments gave similar 
enantioselectivity induction as X16 and very high regioselectivity . For example CAHB 
of the substrate X18 with ligands L2a affords the respective γ-dioxaborato amides X(18)-
1 in excellent levels of enantiomeric purity (95% ee, Table 3). 
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Table 3   Catalytic hydroboration of 1,1-disubstituted phenyl amide X(18),X(19) and 
X(20) with TMDB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* % Yield and % ee are representative of the γ-hydroxyamide isomer 
 
Ligand % yield  % ee 
L2a 72 95 
L2c 72 91 
L2d 70 80 
L1 50 55 
L3a 60 39 
 
Ligand % yield  % ee 
L2c 75  88 
L2d 55  86 
L2a 79 93 
L1 45  50 
 
Ligand % yield  % ee 
L2b 30 55 
L2c 70  82 
L2d 71  70 
L2a 79 90 
L1 62 55 
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  Our initial objective in this investigation had been to design a useful chiral catalytic 
system capable of operating a diverse set of substrates. It was apparent from the 
screenings of previous substrates that there was no significant steric difference between 
them. While we have observed significant success with these systems, we are aware of 
the limitations inherent in alkene substituent pattern so we felt that it is important to 
introduce a bulky substituent and experimentally explore the aspects of reactivity. We 
therefore selected X19 and X20 where we observed that these substrates can react with 
CAHB and afford high enantiomeric excess. For instance, while CAHB of X19 produces 
X(19)-1 in moderate yields (79%, 90% ee .Table 3), X20 affords X(20)-1 in nearly same 
higher yield (79%, 93% ee. Table 5).  
Although currently confined to a small window of substrates, the following investigation 
introduces a new olefin pattern. We synthesized and studied X21 and X22 substrates that 
may hold greater potential for constructing a biological target molecules. Products 
furnished from these reactions are structurally stable and may be employed for 
subsequent Pd-catalyzed cross-coupling. Under the same conditions, these substrates had 
furnished highly enantiopure products up to 94% with very good regioselectivity when 
L2a has been employed. 
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Table 4   Catalytic hydroboration of 1,1-disubstituted  phenyl amide X21 and X22 with 
TMDB 
 
 
 
Ligand % yield  % ee 
L2a 72  94 
L2c 59 77 
L2b 60  78 
L1 61  56 
 
 
 
 
 
 
 
 
*% Yield and % ee are representative of the γ-hydroxyamide isomer 
 
Ligand % yield  % ee 
L2a 70  92 
L2c 59  75 
L1 40  50 
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2.4   The influence of boranes in CAHB of 1,1-disubstituted alkene 
The Takacs group36 studied the reactivity of boranes in directed CAHB and found that the 
nature of the structure of the borane is a key factor in the determining level of 
enantioselectivity. For example, CAHB of the test substrate illustrated in Scheme 7 by 
B1, a five-membered ring borane, gives product in lower enantiomeric excess (75%, 83% 
ee) than the six-membered ring homologue B4 (78, 96% ee). 
 
 
 
Scheme 7   The influence of boranes structure in CAHB of β,γ-unsaturated weinreb 
amide. 
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Table 5 summarizes the chemical yield, regioselectivity (i.e., % γ- and % β-products 
formed) and enantioselectivity for the γ-product as a function of borane in the CAHBs of 
X16; the same chiral catalyst system formed from L2a is used in each case. The results 
obtained using the six-membered ring dioxaborinanes, that is B2 and B4, are on average 
more selective (average of 87% ee) than those obtained on average using the five-
membered ring dioxaborolanes, B1 and B3 (66% ee). Furthermore, the γ / β ratio with B2 
and B4, are on average higher (average of 6.3) than those obtained on average using, B1 
and B3 (average of 2.3).The two six-membered ring boranes, the trimethyl derivative B2 
(TMDB, 94% ee) and pinacol-like tetramethyl derivative B4 (91% ee), afford quite 
similar results. Comparing specific five- and six-membered ring boranes with similar 
methyl substitution patterns finds some differences. For example, B1 affords with L2a 
(66%, 60% ee) while B4 affords (82%, 91 ee%). It was on the basis of this short study 
that TMBD (B2) was selected for the screenings of phenyl amides (X16-X22). During the 
hydroboration reaction, the majority of boranes led to form γ-products as major products 
with considerable amount of undesirable products such as β- products, this perhaps due to 
the size of alkyl group at β- position (scheme 8). 
 
Scheme 8 Catalytic hydroboration of 3-methyl-3-butenoic acid phenyl Amide X16 with 
variety of Boranes. 
  
 
3
5
 
 
Table 5  Catalytic hydroboration of 3-methyl-3-butenoic acid phenyl Amide X16 with variety of boranes. 
 
* Yield determined by crude 1H NMR with mesitylene as an internal standard; enantioselectivities determined by HPLC 
analysis.  
   
B1 
 
 
  
B2 
   
B3 
 
 
  
B4 
 
L γ % 
  
% ee (γ) β % 
 
γ % % ee (γ) β% γ % % ee (γ) β% 
 
γ % % ee (γ) β % 
 
L2a 
 
66 60 34 81 94 13 53 75 41 82 91 12 
 
L2b 
 
65 50 24 40 88 30 36 73 28 64 89 5 
 
L2c 
 
58 52 36 62 84 25 31 79 43 80 79 10 
 
L2d 
 
62 48 23 60 80 30 34 75 41 79 87 10 
 
L1 
 
75 62 11 80 63 18 65 65 22 78 66 7 
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We also examined the borane influence on the catalytic efficiency and level of 
enantioselectivity in another substrate X19 with the expectation that it would provide 
additional insight into the reaction. A similar trend in enantioselectivity is found for the 
CAHB of X19 compared to X16. TMDB (B2) give high enantioselectivity (90% ee). 
However, unlike X16, only small amount of the β-isomer are formed presumably due to 
increased steric hindrance at the β-position due to the cyclohexyl substituent. As 
discussed earlier in this chapter, reagents and conditions have been identified for which 
directed CAHB is very efficient with TMDB enabling the asymmetric hydroboration of 
1,1-disubstituted substrates to be developed into a highly enantiomeric and practical 
reaction. 
Table 6  Catalytic hydroboration of 3-cyclohexyl-3-butenoic acid phenyl amide X19 with 
variety of boranes 
 
* The yield determined by 1H-NMR, the enantiomeric excess determined by HPLC. 
  B1   B2   B3  
L γ %  % ee (γ) β % γ % % ee (γ) β% γ % % ee (γ) β% 
L2a 79 60 3 74 70 7 79 90 3 
L2c 78 55 3 74 70 7 70 82 3 
L2d 75 5 4 78 60 3 71 70 2 
L1 58 64 3 76 50 2 62 55 2 
L3 70 -15 5 45 40 3 30 -55 5 
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2.5 A More Detailed Summary of pinBH Data for Comparison Purposes 
While some data are presented in the preceding two tables, we studied the efficiency and 
selectivity of CAHB with pinBH (B1) in greater detail since this reagent has often been 
used for catalyzed hydroboration and is commercially available, stable, easily stored and 
(if needed) easily prepared.46 Neither the borane reagents nor the modified catalysts were 
able to reach the enantioselectivity and regioselectivity obtained from TMDB.The results 
of this study are summarized in tables 7, 8 & 9.  
Table 7 Catalytic hydroboration of 1,1-disubstituted phenyl amides X17, X18 and X20 
with pinBH. 
 
   
Ligand % yield % ee Ligand Yield % ee Ligand Yield ee % 
L2a 63 67 L2a 68 60 L2a 80 75 
L2c 60 68 L2c 71 55 L2c 72 65 
L2d 64 53 L2d 65 45 L2d 71 60 
L1 57 50 L3a 75 -32 L1 60 53 
- - - L1 64 62 - - - 
*% Yield and % ee are representative of the γ-hydroxyamide isomer 
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The CAHB of the X18 substrate proceeds smoothly and goes to completion when using 
pinBH borane. However, the enantioselectivity induction is not improved when changing 
the borane source from TMDB to pinBH the same trend observed in X21 and X22. The 
summary of this screening are located in Table 8. 
Table 8 Catalytic hydroboration of 1,1-disubstituted phenyl amides X21 and X22 with 
pinBH 
 
 
 
Ligand Yield ee % Ligand Yield e.e % 
L2a 62 60 L2a 64 67 
L2c 72 51 L2c 68 45 
L2b 63 43 L1 53 40 
L1 75 34 - - - 
 
*% Yield and % ee are representative of the γ-hydroxyamide isomer 
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Overall, 4,4,6-trimethyl-1,3,2-dioxaborinane (TMDB (B2)), has been also found to be an 
excellent borane reagent for directed CAHB; it is generally more reactive and selective 
than pinBH and yet stable and easily prepared.47 
To survey the role of the ligands, we have done CAHB using Rh(nbd)2BF4 in conjunction 
with TADDOL-derived monophosphite, TADDOL-derived phosphoramidites or BINOL-
derived monophosphoramidite and pinBH  affords, after oxidative work-up, β-
hydroxyamides. The results are summarized in Table 9. 
 
 γ                                                   β 
 
 
  
 
Scheme 9   Catalytic hydroboration of X16 phenyl amide with variety of ligands. 
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Table 9   Catalytic Hydroboration of X16 phenyl amide with variety of ligands 
 
 
 
 
                                                                                       
 
 
 
 
 
 
 
 
Regardless of the ligand used (i.e., TADDOL-derived monophosphite, TADDOL-derived 
phosphoramidite, or BINOL-derived monophosphoramidite), CAHB with pinBH affords 
the γ-hydroxy amide as the major product (Table 9). However, the various ligands do 
affect the product ratio suggesting that small changes in the ligand scaffold alters the 
topography at the site of catalysis in a significant way. The TADDOL-derived 
monophosphites (i.e., L2a, L2b, L2c and L2d) behave similarly giving predominantly 
the corresponding γ-hydroxy product after oxidative workup. Among the ligands studied 
here, this group ligand gives the highest amount of β-hydroxy product. For example, 
CAHB with L2a, and L2c yield 34% & 36% of the β-product, respectively. Directed 
Ligand γ % % ee β % 
L2b 
 
65 50 24 
L2d 
 
62 48 23 
L2c 
 
58 52 36 
L2a 
 
66 60 34 
L1 
 
75 62 11 
L3a 
 
92 -18 1 
L3c 
 
92 -40 1 
L3d 
 
90 -34 1 
L3b 
 
89 -15 2 
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CAHB of X16 by pinBH with TADDOL-derived phosphoramidites L3a, L3b, L3c and 
L3d give high yield 89-92% of the γ-product indicating very high regioselectivity; less 
than 2% of the β-isomer is found with these ligands.  Unfortunately, the level of 
enantioselectivity induced by those ligands is low, only an average of 32% ee. Similarly, 
the BINOL-derived phosphoramidite generates the γ-hydroxy product predominantly but 
with a modest level of enantioselectivity (75, 62% ee).  Finally, it is also noteworthy that 
enantioswitching is observed in the some cases for the CAHB of X16 by pinBH. 
Enantioswitching.48 describes the situation where similar ligand scaffolds of the same 
absolute configuration give enantiomeric products. For example, compare the results 
obtained with L3c  give -40 % ee while L2a give 60% ee. There is no general 
mechanistic rationale accounting enantioswitching. Similarly, it is difficult to rationalize 
why the yield changes with small structural and electronic changes in the ligands. These 
differences may simply reflect significant and essential differences in catalyst reactivity, 
structure, and/ or the reaction mechanism. 
 
2.6 Exploration into application of boronates  
The CAHB of 1,1-disubstituted substrates exhibits high selectivity producing chiral 
organoboronate derivatives which can be either be oxidized to give the non-racemic 
chiral alcohol or potentially used in other transformations. To illustrate the latter,treating 
the chiral organoboronate with KHF2 gives the trifluoroborate salt. These can be used in 
Suzuki-Miyaura coupling.11 For example, organoboronate is obtained in good yield 
(53%) from X16 (R=Me). Scheme 10 shows the subsequent transformations to illustrate 
its synthetic utility.  
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Scheme 10   (a)  aq NaOH, H2O2; (b) KHF2, MeOH/H2O; (c) 5%Pd(OAc)2, 10% 
RuPhos, Ar-X, K2CO3, toluene/H2O, 80 oC (Ar-X= Chlorobenzene.yield=81%).  
 
In summary the directed CAHB of 1,1-disubstituted alkene has proven to be rewarding. 
High level of high levels of regio- and enantioselective control can results in CAHB of a 
β,γ-unsaturated amide framework. Furthermore, we also studied directed CAHB of 1,1-
disubstituted alkenes consisting of a more synthetically versatile directing groups in the 
following Chapter.   
 
 
 
 
43 
 
 
Chapter 3.1  Catalytic asymmetric hydroboration of β,γ-unsaturated ester and 
weinreb amides 
 The use of a phenyl amide as a directing group has played a major role in the 
direct CAHB reaction developed in the Takacs group as is apparent from the results 
described in Chapter 2. For example, CAHB of X18 by 4,4,6-trimethyl-1,3,2-
dioxaborinane (TMDB) catalyzed by Rh(nbd)2BF4 in conjunction with the TADDOL-
derived phosphite L2a affords -dioxaborato amide X(18)-1 in excellent enantiomeric 
purity (72%, 95% ee); only a trace of the β-substituted product is found (<3%). We 
sought to expand the scope of the directed CAHB of 1,1-disubstituted alkene by opening 
options for subsequent chemistry. Accordingly, we investigated other directing groups for 
the 1,1-disubstituted alkenes at hand. In this chapter, we report that the tert-butyl ester 
moiety promotes the directed CAHB utilizing the same chiral rhodium catalyst. For 
example, CAHB of X23 affords X(23)-1 in the similar yield and similarly high 
enantiomeric purity as the corresponding phenyl amide. The reaction proceeds with good 
regiocontrol as well; only a trace amount of the β-hydroxy ester is formed. Oxidative 
workup with basic hydrogen peroxide leads to cyclization of the γ-hydroxy ester to the  
γ-lactone. 
In evaluating the directed CAHB of X23, several BINOL-derived phosphoramidite, 
TADDOL-derived phosphite, and phosphoramidite ligands derivatives were examined 
from the list shown below. The reactivity and enantioselectivity vary widely. Overall, 
directed CAHB of the tert-butyl ester derivatives with pinBH gives good reactivity with 
moderate enantiomeric induction; generally they afford results similar to those obtained 
from the corresponding phenyl amide substrate. For example, the CAHB of the X23 in 
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presence of L2a and pinBH furnish, after oxidation, γ-hydroxy alcohol in (57, 81% ee); 
the CAHB of the phenyl amide X16 in presence of L2a and pinBH furnish γ-hydroxy 
alcohol (66, 60% ee). Certain ligands derived from the TADDOL scaffold afford 
catalysts that exhibit good enantioselectivity. For example, the parent TADDOL-derived 
phenylphosphite L2c affords X(23)-1 in 75% ee and the corresponding (3,5-
dimethyl)phenyl analogue L2d gives 69 % ee (Table 10). 
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Table 10  Catalytic hydroboration of 3-methyl-3-butenoic acid tert-butyl ester X23 with 
pinBH. 
Ligands Yield % ee % 
L2a 57 81 
L2c 50 75 
L2d 52 69 
L1 49 72 
L3 58 -10 
  
 
The previous screening of phenyl amide substrates it was found that TMDB increases the 
enantioselectivity compared to pinBH. It was therefore expected that directed CAHB of 
the tert-butyl ester substrates by TMDB would again give higher levels of 
enantioselectivity. As summarized in Table 11, this proved to be the case. The 
enantioselectivity increases in each case; L2a gives the highest enantiomeric excess 
(94%) among the group of ligands. For example, the CAHB of the X23 in presence of 
L2a and TMDB furnish γ-hydroxy alcohol (63, 94% ee) and in presence of L2d furnish 
γ-hydroxy alcohol (63, 92% ee). It is worth noting that the BINOL-derived 
phosphoramidite L1 also gives improved enantioselectivity, 82% ee with TMDB, as 
compared to 72% ee with pinBH. The high degree of stereoselectivity obtained with the 
tert-butyl ester moiety should provide a powerful method for stereoselective construction 
of a chiral intermediate for target-directed synthesis. 
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Table 11  Catalytic hydroboration of 3-methyl-3-butenoic acid tert-butyl ester X23 with 
TMDB. 
Ligands Yield % ee % 
L2a 63  94 
L2c 60  88 
L2d 63  92 
L1 50  82 
L3a 59  -23 
 
 
To explore the scope a second tert-butyl ester substrate bearing an alkyl substituent in β-
position was prepared. The benzyl group was chosen because it often enables more rapid 
and efficient access to structurally novel chemical libraries.49 The results of the CAHB of 
X24 by pinBH and TMDB are summarized in tables 12. For the three ligands examined, 
the regio and enantioselectivity observed was higher than the corresponding reaction with 
pinBH. The highlight of this study was the regioselectivity of the products, generating a 
single regioisomer at the γ-position. 
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Table 12     Catalytic hydroboration of 3-benzyl-3-butenoic acid tert-butyl  X24 with 
pinBH and TMDB. 
 
Ligands 
 
 
Yield % ee % Yield % ee % 
L2a 64  61 80  95 
L2b 62 57 72 82 
L2c 51  30 79  92 
 
From the studies conducted above and those carried out by others in the Takacs group, it 
was concluded that, for the 1,1-disubstituted substrates under investigation, the levels of 
asymmetric induction are highest for CAHB by TMDB using catalysts modified by the 
3,5-diMe(TADDOL)POPh ligand (i.e., L2a). Thus, L2a was the best ligand to work with 
in exploring the reactions of other substrates in the hopes of developing a catalytic system 
to construct novel target molecules and use this strategy for chemical synthesis. Further 
screening reactions were carried out to continue to investigate the scope of this reaction 
with respect to the β-substituent (Scheme 11). The results are summarized in Table 13. In 
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each case, the lactone was produced in moderate to good yield and in 90-95% ee; only 
trace amounts of the β-regioisomer products were observed. 
 
 
 
Scheme 11  Catalytic hydroboration of tert-butyl esters with TMDB and L2a ligand . 
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Table 13   The results of catalytic hydroboration of tert-butyl esters with TMDB and L2a 
ligand. 
 
Entry Ester Product Yield ee% 
X23 
 
 
 
62 94 
X24 
 
 
80 95 
X25 
 
 
 
65 91 
X26 
 
 
 
76 91 
X27 
 
 
 
63 94 
X28 
 
 
 
61 90 
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3.2 Catalytic asymmetric hydroboration of 1,1-disubstituted weinreb amides 
We also briefly examined the potential of using Weinreb amides at the directing group 
for directed CAHB. Weinreb amide derivatives are also useful functional groups for 
further synthetic transformation. CAHB of Weinreb amide X29 by CatBH and pinBH 
was screened using Rh(nbd)2BF4 in conjunction with TADDOL-derived phosphite 
ligands and BINOL-derived monophosphoramidite ligands; the results are summarized in 
Table 14.  Using pinBH, the level of enantioselectivity is generally low. For example, the 
CAHB of X29 by pinBH using L2c gives the γ-hydroxy product in 50% yield and 50% 
ee. CAHB of the same substrate by TMDB generally gives improved levels of 
enantioselectivity generally across the series of TADDOL- and BINOL-derived 
monophosphites and phosphoramidites. For example, CAHB of X29 by TMBD using 
L2a generates the γ-hydroxy products in 91% ee, however, the yield (45%) remains only 
modest in these preliminary experiments. 
Scheme  12  Catalytic hydroboration of 5-methyl-3-methylidenehexanoic acid weinreb 
amides X29 with pinBH and TMDB. 
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Table 14  The results of catalytic hydroboration of 5-methyl-3-methylidenehexanoic acid 
weinreb amides X29 with pinBH and TMDB 
 
Ligands 
 
 
Yield % ee % Yield % ee % 
L2a 48 45 45 91 
L2c 50 50 50 75 
L2d 40 30 30 70 
L1 20 25 38 20 
 
* % Yield and % ee are representative of the γ-hydroxyamide isomer 
 
The results in Table 13 suggest that the methodology should be very amenable to the 
stereoselective construction of chiral γ-hydroxy esters and β-substituted-γ-lactones. We 
attempted to construct the γ-phenyl lactone X30, a precursor to (R)-(-)-baclofen,50 which 
is a therapeutically effective GABAB receptor agonist.51 Unfortunately, this reaction did 
not proceed smoothly and the desired products were not formed cleanly under this 
condition because of alkene reduction and β-substitution. Although this application 
failed, the methodology has been successfully used by others in the Takacs group to 
prepare lignan precursors in good yield and high enantiomeric purity. Other potential 
applications are discussed in the following section. 
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Scheme 13   Attempted route for the preparation of β-phenyl-γ-butyrolactone 
 
3.3 Potential applications of the directed CAHB of unsaturated esters in synthesis. 
 
The rhodium-catalyzed directed CAHB reaction is developing into one of the most 
versatile and general methods developed for the preparation of highly enantiomeric 
selectivity of organoboronates. We envision that this method will ultimately serve in the 
asymmetric synthesis of variety of heterocyclic and carbocyclic compounds that found 
application in both medicinal and material chemistry.1,2,3,6 In the case of β,γ-unsaturated 
amides and esters, 1,1-disubstituted substrates react to form products with a high degree 
of regio- and enantioselectivity. For example, CAHB of X23 followed by work up with 
hydrogen peroxide and aqueous sodium hydroxide yields lactone X(23)-1 in excellent 
enantiomeric purity (62%, 94% ee). This lactone offers unique advantages as an 
intermediate for asymmetric synthesis and has been used in asymmetric total synthesis 
(Scheme 14). For example, Riaz reported the isolation and separation of the desired 
isomer of this lactone and used it to carry out a more expeditious and efficient synthesis 
of xyloketal. The latter compound has attracted attention due to its unusual C3-symmetric 
structure and it’s as a potent inhibitor of acetylcholine esterase.52  
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Scheme 14 Representative examples of applications of CAHB of 3-methyl-3-butenoic 
acid tert-butyl ester X23. 
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CAHB of X23 followed by mild oxidative workup (NaBO3, THF/H2O) gives β-hydroxy 
ester X(23)-2 (Scheme 14). The latter compound has served as a key intermediate in 
several total syntheses, for example, in the multi-step synthesis of amphidinolide X.53 The 
latter compound was the first macrodiolide consisting of polyketide-derived diacid and 
diol units isolated from natural sources; it possesses moderate cytotoxicitiy against L1210 
and KB cell lines.54 Fujimoto55 used the same intermediate in his synthesis of muscone, 
the component of musk used in many perfumes. Nakamura56 prepared stink bug 
pheromones from this same intermediate. 
    Other β-substituted- γ-lactones prepared by directed CAHB have similarly found used 
as intermediates in asymmetric total syntheses. For example, Lee used γ-butyrolactones 
X(26)-1 in a key step of his synthesis of enantiomerically pure Pregabalin, an 
anticonvulsant drug used for neuropathic pain.57Peter reported the alkylation of β-benzyl-
γ-butyrolactone X(24)-1 enroute to several symmetric and unsymmetric lignan homologs 
(Scheme 15).49 
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Scheme 15   Preparation of biologically active chiral β-substituted-γ-lactones via CAHB 
 
In summary, the recent development of directed CAHB reactions directly produce chiral 
intermediates that are associated with natural products synthesis and it is expected that 
the continued development of these methodologies will contribute to other new 
applications in asymmetric total synthesis.  
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Chapter 4: Concluding remarks 
    We provided efficient method in catalytic hydroboration of 1,1-disubsituted alkene 
using two-point binding methodology. This method furnishes chiral organoboronates in 
high enantiomeric purity. The reactions of several 1,1-disubstitued alkenes within a β, γ- 
unsaturated carbonyl framework  including  phenyl amide, esters, Weinreb amide under 
several reaction conditions and catalyst systems  were investigated in this thesis.  Since a 
little change in topography of chiral ligands has direct influence in the hydroboration 
outcomes, we postulated that the use of an assortment of TADDOL- and BINOL-derived 
monophosphites and phosphoramidites could serve as suitable ligands for selective 
directed hydroboration for 1,1-disubstituted alkene.  Using structurally-similar boranes 
has significant effects not only on the regioselectivity but also on the enantioselectivity of 
the products. 
    The presence of directing group can serve an efficient tool in controlling the 
stereoselectivity in CAHB.  To test this hypothesis in 1,1-didubstituted alkene within a β, 
γ-unsaturated carbonyl framework,  the X16 substrate was subjected to the CAHB in 
presence of 1 % Rh(nbd)2BF4 in combination with  2.1% 3,5-diMe(TADDOL)POPh  
(L2a)  and 4,4,6-trimethyl-1,3,2-dioxaborinane (TMDB (B2)) affords γ-dioxaborato 
amide X(16)-1 in good yield and excellent enantiomeric purity (53%, 95% ee); and tert- 
butyl ester were proven to be an excellent directing moieties in the CAHB of 
1,1disubstituted alkenes. For example,  the X23 substrate was subjected to the CAHB in 
presence of 1 % Rh(nbd)2BF4  in conjunction with  2.1% 3,5-diMe(TADDOL)POPh  and 
TMDB produced γ-dioxaborato ester X(23)-1 in good yield and excellent enantiomeric 
purity (62%, 94% ee). The Weinreb amide also permits the efficient two-point binding 
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from the carbonyl and olefin moieties. For example, CAHB of  weinreb amide derivative 
X29 gave promising results (45%, 91% ee).   
  The 1,1-disubstituted alkenes  substrates investigated within  this study involve varying 
degrees of reactivity and enantioselectivity  with many ligands and boranes.   The most 
promising results are listed in Table 15. 
Table 15 Results of CAHB of 1,1-disubstituted alkene  
Substrate Yield  % ee % 
 
 
53 95 
 
60 92 
 
80 95 
 
72 90 
 
71 93 
 
73 94 
 
 
55 94 
58 
 
 
 
Substrate Yield  % ee % 
 
 
62 94 
 
 
65 91 
 
 
78 91 
 
 
80 95 
 
 
67 92 
 
 
63 94 
 
45 91 
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    The ability to produce chiral organoboronates through CAHB of two bond binding 
substrate provides unique opportunities for the accomplishment of verity enantioselective 
reactions. This protocol offers highly regio-and enantioselectivity, making them 
extremely powerful tools for synthesis of stereochemically products.  
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Chapter 5: Experimental Data 
General procedures.  Reactions were carried out in a dry nitrogen atmosphere. 
Dichloromethane (DCM) and tetrahydrofuran (THF) were freshly distilled under the 
following conditions: THF from sodium metal and benzophenone, and DCM from 
calcium hydride. HPLC solvents were filtered through Millipore filter paper. When 
indicated in the following procedures, solvents were degassed by freezing under reduced 
pressure followed by a dry nitrogen atmosphere thaw (3–4 times). 4,4,6-Trimethyl-1,3,2-
dioxaborinane TMDB was distilled immediately before use. All synthesized compounds 
were purified with flash chromatography using EMD Silica Gel 60 Geduran®, distilled 
via short path distillation, or triturated. Thin Layer Chromatography analyses were 
performed on Analtech Silica Gel HLF (0.25 mm) precoated analytical plates and 
visualized with use of handheld short wavelength UV light, iodine stain (I2 and EMD 
Silica Gel 60 Geduran®) or vanillin stain (ethanol, H2SO4, and vanillin). HPLC analyses 
were performed with use of an ISCO model 2360 HPLC and Chiral Technologies, Inc. 
chiral HPLC columns (Chiralcel OD; column: 250 x 4.6 mm) Data were recorded and 
analyzed with ChromPerfect chromatography software (version 5.1.0). NMR spectra 
were recorded on 600, 400, and 300 MHz Bruker Advance NMR spectrometers using 
residue CHCl3 (δ 7.27 ppm) or CDCl3 (δ 77.0 ppm) for reference unless otherwise 
specified. Peaks are expressed as m (unresolved multiplet), q (quartet), t (triplet), d 
(doublet) or s (singlet). IR spectra were recorded using an Avatar 360 FT-IR. Optical 
rotations were measured as solutions, 1.0 g/100 mL in chloroform unless indicated 
otherwise, and recorded using an Autopol III automatic polarimeter. HRMS analyses 
were performed by the Nebraska Center for Mass Spectrometry.   
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Representative procedure for the preparation  of allylic acid  
 
   Preparation of 3-methyl-3-butenoic acid (X1): Magnesium turnings and a few 
crystals of iodine were added to 400 mL of freshly distilled THF (dry) in three necked 
1000 mL round bottom flask equipped with a stir bar and condenser. The allylic chloride 
(16.21 g, 180 mmol) was diluted by twice its volume with THF and added to a dropping 
funnel. A portion of the allyl chloride solution (ca. 50 mL) was added to the magnesium 
turnings; exothermic reaction ensued causing the THF to reflux. (Note: if the mixture did 
not heat to reflux, more allyl chloride (ca 20 mL) was added and the mixture gently 
heated to reflux using a heat gun). The remaining allyl chloride solution was added 
dropwise at a rate sufficient to maintain a gentle reflux. Upon complete addition, the 
cooling reaction was allowed to stir for 30 min under N2 turning milky white. The 
mixture was cooled to -78oC (30 min). Afterwards, a steady stream of CO2 blanketed the 
mixture for (ca 1 h). The temperature was slowly allowed to increase to 0 oC by removing 
the cold bath. The pH was then adjusted to 10-11 by the addition of cold 2 M aq NaOH 
and extracted with diethyl ether three times. The mixture was then acidified with cold 4 
M   HCl to pH 2-3 and extracted three times with diethyl ether. The organic solvent was 
concentrated under reduced pressure to affords after flash chromatography on silica gel 
(50:50 Hexanes:Ethyl acetate), the title compound (6g, 33%) as a light yellow oil; TLC 
analysis Rf 0.30 (50:50 hexanes :dichloromethane); 1H NMR (CDCl3, 400 MHz) δ 11.82 
(1H, br s, OH), 4.96 and 4.89 (2H, s’s, d), 3.09 (2H, s, b), 1.84 (3H, s, e); 13C NMR (100 
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MHz, CDCl3) δ 177.97 (a), 137,06 (c), 115.60 (d), 43.31 (b), 22,62 (e) ; IR (neat) 
2975.5(CH sp2 stretch) and 1652 cm-1. 
 
Representative procedure for the preparation of allylic alcohols.58 
 
     General procedure illustrated for the preparation of 2-methylene-4-phenylbutan-
1-ol (X2): Into a flame-dried three-neck RBF with condenser and a dropping funnel under 
N2 was added THF (40 mL), magnesium turnings (2g, 88 mmol) and a tiny crystal of I2. 
A solution of (2-bromoethyl) benzene (8.0 g, 88 mmol) in THF (10 mL) was added drop 
wise while reaction was initiated by heating with a heat gun. After the addition of (2-
bromoethyl) benzene was complete, the reaction was stirred for 3 hours. The mixture was 
then cooled to 0 oC and transferred via cannula into a cooled (-70 °C) suspension of 
copper iodide (5.0 mmol, 50 mol %) and propargyl alcohol (10.0 mmol) in dry toluene 
(15 mL). which was followed by a natural warming to room temperature. After complete 
conversion of the starting material (ca. 18 h) the reaction mixture was cooled to 0 °C, 
quenched by the addition of saturated NH4Cl and extracted with diethyl ether (3 X 30 
mL). The combined extracts were dried (anhyd. MgSO4). The solvent was evaporated 
and the crude product purified by flash chromatography (85:15 Hexane: ethyl acetate) to 
afford the title compound (2.5 g, 58 %) as a colorless oil; TLC analysis Rf 0.50 (60:40 
hexanes:ethyl acetate); 1H NMR (CDCl3, 400 MHz) δ 7.36-7.33 (2H, t, J =8, g,g’), 7.27-
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7.25 (3H, d, J=8, h,h’ ,i), 5.12 and 4.98 (2H, s’s, c), 4.14(2H, s, a), 2.87(2H, t, J=4, d) 
2.41(2H, t, J=8, e), 2.34 (1H, br s, OH); 13C NMR (CDCl3, 100 MHz) δ148.44(b), 141.09 
(f), 128.40(h,h’), 128.38(g.g’), 125.96(i), 109.05(c), 65.92(a), 34.66 (e), 34.30(d); IR 
(neat)  3325 (OH stretch), 2922 (OH bend), 1018, 1056, 1453(C-O stretch), 647, 729. 
HRMS (FAB) calcd. for C11H14O (M+Na): 185.0942, found 185.0939 m/z. 
 
 
 
    Preparation of Preparation of 2-cyclohexyl-2-propenol (X3): Following the general 
procedure, cyclohexylmagnesium chloride (45 mL of a 2.0 M solution in THF, 90 mmol) 
and propargyl alcohol affords the title compound (3.33 g, 79%) as a colorless oil after 
flash chromatography over silica gel (80:20 hexanes:ethyl acetate); TLC analysis Rf  0.40 
(75:25 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 5.00 and 4.86(2H, s’s, c), 
4.10(2H, s, a), 2.00–1.85(2H, m, a, OH), 1.85–1.70 (4H, m, e,e’, f,f’), 1.70–1.65(1H, m, 
g), 1.30–1.10(5H, m, e,e, f,f’, g); 13C NMR (75 MHz, CDCl3) δ 154.53(b), 107.40(c), 
65.05(a), 41.25(d), 32.43(e,e’), 26.70(f,f’), 26.29(g); IR (neat) 3306 (O-H stretch), 2850, 
1649, 1060, 1019 (C-O stretch), 889, 625 cm-1; HRMS (EI) calcd. for C9H16O: 140.1201, 
found 140.1204 m/z. 
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    Preparation of 2-Phenyl-2-propenol (X4): Following the general procedure, 
phenylmagnesium bromide (90 mL of a 1.0 M solution in THF, 90 mmol) and propargyl 
alchol affords, after flash chromatography on silica gel (80:20 hexanes:ethyl acetate), the 
title compound (3.08 g, 77%) as a light yellow oil; TLC analysis Rf 0.30 (75:25 
hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.55–7.45 (2H, m, e,e’), 7.45–7.30 
(3H, m, f,f’, g), 5.50 and 5.39 (2H, s’s, c), 4.55 (2H, s, a), 2.28 (1H, br s, OH); 13C NMR 
(75 MHz, CDCl3) δ 147.30 (b), 138.60 (d), 128.53 (f,f’), 127.94 (g), 126.10 (e,e’), 112.55 
(c), 64.87 (a); IR (neat) 3370 (O-H stretch), 2945, 2883, 1735, 1632, 1495, 1444, 1372, 
1239, 1043 (C-O stretch), 1024, 902, 778, 706, 609 cm-1. 
Representative procedure for the preparation of allylic carbonates 59 
 
 
     Preparation of 2-phenylethyl ethyl carbonate (X5):  To a cooled (0 oC) solution of 
the allyl alcohol (50 mmol) and dry pyridine (100 mmol) in THF (100 mL) was added 
ethyl chloroformate (50 mmol) dropwise over 10 min. The mixture was stirred at room 
temperature for 3 h and then partitioned between dilute aq. hydrochloric acid and ether 
(ca. 150 mL each). The aqueous phase was extracted with an additional potion of ether, 
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the combined organic layers washed with brine, and dried (anhyd. MgSO4). Following 
evaporation of the solvent, flash chromatography on silica gel (90:10 hexanes:ethyl 
acetate) gave the title compound (9.37 g, 80%) as a color less oil; TLC analysis Rf 0.70 
(90:10 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3)  δ 7.33(2H, m, g,g’), 7.22-
7.25(3H, m, k,k’, i), 5.16 and  5.06(2H, s’s, f), 4.64(2H, s, d), 4.24(2H, q, J=4, b), 
2.84(2H, t, J=8, h), 2.45(2H, t, J=8,  g), 1.36(3H, t, J=5, a);  13C NMR (100 MHz, CDCl3) 
δ 155(c), 142.93(e), 141.53(i), 128(k,k’), 128.37(g,g’), 126.00(l),113.43(f), 70.12(d), 
64.06(b), 34.76(g), 34.02(h), 14.31(a);  IR (neat) 1742 (C-O stretch), 1374, 1435, 1496 
(C-O stretch), 2933(CH sp2 stretch), 698, 908, 1007; HRMS (FAB) calcd. for 
C14H18O3(M+Na): 257.1154, found 257.1154 m/z. 
 
    Preparation of 2-cyclohexylallyl ethyl carbonate (X6): To a cooled (0 °C) solution 
of 2-cyclohexylallyl alcohol (2.80 g, 20 mmol) and pyridine (3.16 g, 40 mmol) in THF 
(30 mL) was added ethyl chloroformate (2.17 g, 20 mmol) dropwise over a period of 10 
min. The resultant reaction mixture was allowed to stir for 3 h and then diluted with a 
solution of dilute HCl (15 mL). The mixture was extracted with diethyl ether (3 x ca. 20 
mL) and the combined organic extracts were dried (anhyd. MgSO4) and concentrated 
under reduced pressure. Flash chromatography on silica gel (95:5 hexanes:ethyl acetate) 
afforded the title compound (3.69 g, 87%) as a colorless oil; TLC analysis Rf 0.75 (95:5 
hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 5.04 and 4.96 (2H, s’s, f), 4.60 
(2H, s, d), 4.20 (2H, q, J = 7.1 Hz, b), 2.00–1.90 (1H, m, g), 1.90–1.75 (4H, m, h,h’, i,i’), 
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1.75–1.65 (1H, m, j), 1.31 (3H, t, J = 7.1 Hz, a), 1.30–1.10 (5H, m, h,h’, i,i’, j); 13C NMR 
(75 MHz, CDCl3) δ 155.07 (c), 148.66 (e), 111.07 (f), 69.35 (d), 63.92 (b), 41.19 (g), 
32.09 (h,h’), 26.56 (i,i’), 26.21 (j), 14.25 (a); IR (neat) 2926, 2853, 1742 (C=O stretch), 
1649, 1448, 1374, 1241 (C-O stretch), 1004, 908, 890, 790, 630 cm-1; HRMS (CI) calcd. 
for C12H21O3 (M+H): 213.1491, found 213.1493 m/z. 
 
    Preparation 2-Phenylallyl ethyl carbonate (X7): Following the representative 
procedure, 2-phenylallyl alcohol (2.68 g, 20 mmol) afforded, after flash chromatography 
on silica gel (95:5 hexanes:ethyl acetate), the title compound (3.46 g, 84%) as a colorless 
oil; TLC analysis Rf 0.75 (95:5 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 
7.50–7.45 (2H, m, h,h’), 7.45–7.30 (3H, m, i,i’, j), 5.60 and 5.45 (2H, s’s, f), 5.06 (2H, s, 
d), 4.23 (2H, q, J = 7.1 Hz, b), 1.33 (3H, t, J = 7.1 Hz, a); 13C NMR (75 MHz, CDCl3) δ 
155.06 (c), 142.15 (e), 137.86 (g), 128.54 (i,i’), 128.14 (j), 126.04 (h,h’), 115.62 (f), 
68.87 (d), 64.15 (b), 14.25 (a); IR (neat) 2984, 1740 (C=O stretch), 1634, 1375, 1242 (C-
O stretch), 1006, 910, 872, 789, 705, 547 cm-1. 
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Representative procedure for the preparation of disubstituted β,γ-unsaturated 
esters. 
 
 
 
    Preparation of 3-methylidene-5-phenylpentanoic acid ethyl ester (X8): A stirred 
solution of the allylic carbonate (5 mmol) and Pd(PPh3)4 (22.4 mg, 0.1 mmol) was 
blanketed with a head space of CO to 60 psi.  The resulting mixture was warmed to 50 oC 
and stirred (24 h). Afterwards, the cooled reaction mixture was partitioned between 
ether/water. The organic layer was dried and concentrated, and the residue was purified 
by column chromatography on silica (80:20 hexanes:ethyl acetate) to give the title 
compound (0.490 g, 45%) as a colorless oil: TLC analysis Rf  0.70 (90:10 hexanes:ethyl 
acetate); 1H NMR (300 MHz, CDCl3)  δ 7.31(2H, m, j,j’), 7.19-7.29( 3H, m, k,k’, l), 4.99 
and 4.97(2H, s’s, f), 4.14(2H, q, J=8, b), 3.10(2H, s, d), 2.79(2H, t, J=8, g), 2.43(2H, t, 
J=8,  h), 1.27(3H, t, J=8,  a);  13C NMR (75 MHz, CDCl3) δ 171.48(c),   141.95(e), 
141.72(i), 128.49(k, k’), 128.35(j,j’), 125.91(i), 114.02(f),  60.69(b), 42.27(d), 37.59(g), 
33.96(h), 14.24(a); IR (neat) 2934 (CH  sp2 stretch), 1735 (C=O stretch), 1154, 1367, 
1387 (CO stretch),746, 654.HRMS (FAB) calcd. For C11H14O2 (M+H): 218.1307, found 
219.1389 m/z. 
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Preparation of 2-phenylethyl ethyl acid  
 
    Preparation of 3-Methylidene-5-phenylpentanoic acid (X9): To the compound ( 
230 mg, 26  mmol) X8 was added methanol 1 mL and 2 N KOH ( 9 mL), and stirred 
overnight at room temperature. The resultant basic solution was extracted with 
dichloromethane (2 x 15 mL) and then acidified. The acidic aqueous layer was extracted 
with dichloromethane (3 x 30 mL) and the combined organic extracts were dried (anhyd. 
MgSO4) and concentrated under reduced pressure. The crude residue was then purified 
via flash chromatography on silica gel (50:50 hexanes:ethyl acetate) to afford the title 
compound (184 mg g, 63%) as a light yellow oil; TLC analysis Rf 0.50 (50:50 
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3)  δ 11.10 (1H, br s, OH), 7.34-
7.30(2H, m, J= 8, h,h’), 7.28-7.21( 3H, m, J= 8, i,i’, j), 5.05 and 5.03 (2H, s’s, d), 
3.16(2H, s, b), 2.81(2H, t, J=8,  e), 2.47(2H, t, J=8,  f); 13C NMR (100 MHz, CDCl3) δ 
178.03(a), 141.54(c), 141.23(g), 128.40(i, i’), 128.35(h,h’), 125.98 (j), 114.79(d), 
41.91(b), 37.48(e), 33.95(f); IR (neat) 3026(OH stretch), 2926 (OH bending), 1703 (C=O 
stetch), 1216, 1293, 1406(C-O stretch), 967, 768, 765. cm-1. HRMS (ESI) calcd. For 
C12H14O2 (M+Na): 213.0891, found 213.0813 m/z. 
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Representative procedure for the preparation of β,γ-unsaturated amides 60  
 
Preparation of 3-methyl-3-butenoic acid phenyl amide (X16): To a cooled (0 
°C) solution of 3-methyl-3-butenoic acid (501 mg, 5.0 mmol) in dichloromethane (DCM, 
10 mL) was added aniline (560 mg, 6.0 mmol) and N,N-dimethylamino pyridine (DMAP, 
61 mg, 0.50 mmol). After the resulting mixture was allowed to stir for 0.5 h at the same 
temperature, N,N-dicyclohexylcarbodiimide (DCC, 1.14 g, 5.5 mmol) was added in one 
portion and allowed to warm to room temperature. After an overnight stir, the reaction 
mixture was filtered and the filtrate was washed with dilute HCl (2 x 15 mL, 1M). The 
organic layer was dried (anhyd. MgSO4) and concentrated under reduced pressure. Flash 
chromatography on silica gel (75: 25 hexanes:ethyl acetate) affords the title compound 
(570 mg, 65%) as a white solid: mp 97–99 ºC; TLC analysis Rf 0.30 (75:25 hexanes:ethyl 
acetate); 1H NMR (400 MHz, CDCl3) δ 7.65 (1H, br s, NH), 7.53 (2H, d, J = 8.0 Hz, 
c,c’), 7.33 (2H, t, J = 7.6 Hz, b,b’), 7.13 (1H, t, J = 7.2 Hz, a), 5.09 and 5.02 (2H, s’s, h), 
3.15 (2H, s, f), 1.88 (3H, s, i); 13C NMR (100 MHz, CDCl3) δ 168.58 (e), 140.35 (d), 
137.80 (g), 128.98 (b,b’), 124.36 (a), 119.79 (c,c’), 116.09 (h), 47.41 (f), 22.46 (i); IR 
(neat) 3291 (N-H stretch), 3060, 2953, 2921, 2865, 1657 (C=O stretch), 1638, 1595, 1525 
(N-H bend), 1440, 1307, 1251 (C-N stretch), 1162, 869, 738, 688, 617 cm-1. 
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      Preparation of 3-Methylidene-5-phenylpentanoic acid phenyl amide (X21): 
Following the general procedure, 3-methylene-5-phenylpentanoic acid (1 g, 5.25 mmol) 
affords, after flash chromatography on silica gel (75:25 hexanes:ethyl acetate), the title 
compound (484 mg, 61%) as a white solid: mp 79–80 ºC; TLC analysis Rf  0.40 (75:25 
hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.48(2H, d, J = 8.0 Hz, l,l’), 7.40–
7.30 (3H, m, c,c’, NH), 7.30–7.25(2H, m, b,b’), 7.25–7.20(3H, m, m,m’,n), 7.14(1H, t, J 
= 6.8 Hz, a), 5.16 and 5.12 (2H, s’s, h), 3.19(2H, s, f), 2.86 (2H, t, J = 8.0 Hz, j), 2.50(2H, 
t, J = 8.4 Hz, i); 13C NMR (100 MHz, CDCl3) δ 168.31(e), 143.69(d), 141.21 (k), 137.66 
(g), 128.99 (b,b’), 128.44 (l,l’), 128.35 (m,m’), 126.06 (n), 124.38 (a), 119.69 (c,c’), 
115.75 (h), 46.25 (f), 37.44 (i), 33.91 (j); IR (neat) 3237 (N-H stretch), 3185, 3061, 3025, 
1652 (C=O stretch), 1596, 1541 (N-H bend), 1469, 1443, 1398, 1346, 1247 (C-N stretch), 
1193, 961, 897, 747, 694, 616 cm-1; HRMS (EI) calcd. for C19H21NO: 279.1623, found 
279.1649 m/z. 
 
Preparation of 3-Cyclohexyl-3-butenoic acid phenyl amide (X19): follow the 
same procedure describe above with carbonylation, A mixture of 2-cyclohexylallyl ethyl 
carbonate      (1.06 mg, 5.0 mmol) and Pd(PPh3)4 (116 mg, 0.10 mmol) was put under a 
pressurized (60 psi) atmosphere of carbon monoxide. The mixture was heated (50 °C) for 
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24 h and then allowed to cool to room temperature and ambient pressure. The resultant 
black mixture was run over a silica plug to afford the crude β,γ-unsaturated ethyl ester. 
The crude residue was taken up in a mixture of Methanol (5 mL) and aqueous 2 M 
Potassium hydroxide (50 mL) and stirred overnight at room temperature. The resultant 
basic solution was extracted with dichloromethane (2 x 15 mL) and then acidified. The 
acidic aqueous layer was extracted with dichloromethane (3 x 30 mL) and the combined 
organic extracts were dried (anhyd. MgSO4) and concentrated under reduced pressure. 
The crude β,γ-unsaturated acid (537 mg, 3.2 mmol) was used in the next step without 
further purification. 
Following the general amidation procedure with DCC, the crude β,γ-unsaturated 
acid affords, after flash chromatography on silica gel (80:20 hexanes:ethyl acetate), the 
title compound (469 mg, 39%, 3 steps) as a white solid: mp 81–83 ºC; TLC analysis Rf 
0.40 (75:25 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.62 (1H, br s, NH), 
7.51 (2H, d, J = 7.8 Hz, c,c’), 7.34 (2H, t, J = 8.1 Hz, b,b’), 7.12 (1H, t, J = 7.5 Hz, a), 
5.15 and 5.06 (2H, s’s, h), 3.19 (2H, s, f), 2.05–1.95 (1H, m, i), 1.90–1.65 (5H, m, k,k’, 
l,j,j’), 1.30–1.10 (5H, m, j,j’,k,k’, l); 13C NMR (75 MHz, CDCl3) δ 168.85 (e), 150.39 (d), 
137.72 (g), 129.00 (b,b’), 124.31 (a), 119.65 (c,c’), 113.79 (h), 44.06 (i), 44.42 (f), 32.18 
(j,j’), 26.48 (k,k’), 26.09 (l); IR (neat) 3330 (N-H stretch), 2921, 2848, 1665 (C=O 
stretch), 1596, 1514 (N-H bend), 1436, 1346, 1245 (C-N stretch), 1167, 956, 905, 749, 
691, 586 cm-1; HRMS (ESI) calcd. for C16H21NaNO (M+Na): 266.1521, found 266.1526 
m/z. 
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    Preparation of 3-Phenyl-3-butenoic acid phenyl amide (X20): Following the 
general procedure, 2-phenylallyl ethyl carbonate (1.03 g, 5.0 mmol) affords, after flash 
chromatography on silica gel (75:25 hexanes:ethyl acetate), the title compound (215 mg, 
18%, 3 steps) as a white solid: mp 90.5–93.5 ºC; TLC analysis Rf 0.40 (75:25 
hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.60–7.50 (3H, m, j,j’,NH), 7.45–
7.35 (5H, m, c,c’,k,k’,l), 7.35–7.25 (2H, m, b,b’), 7.10 (1H, t, J = 7.5 Hz, a), 5.78 and 
5.41 (2H, s’s, h), 3.65 (2H, s, f); 13C NMR (75 MHz, CDCl3) δ 168.35 (e), 142.08 (d), 
138.76 (i), 137.61 (g), 128.94 (b,b’), 128.82 (j,j’), 128.47 (l), 125.78 (k,k’), 124.43 (a), 
119.84 (c,c’), 117.44 (h), 45.14 (f); IR (neat) 3248 (N-H stretch), 3192, 3135, 3085, 
2929, 1804, 1656 (C=O stretch), 1597, 1554 (N-H bend), 1484, 1441, 1338, 1232 (C-N 
stretch), 1162, 896, 770, 752, 688 cm-1. 
 
Representative procedure of preparing phenyl amide via tert-butyl ester approach  
 
 
 Preparation of 5-methyl-3-methylidenehexanoic acid phenyl amide (X18): To 
tert-butyl ester X26 (595 mg, 3.0 mmol) was added trifluoroacetic acid (CF3CO2H, 8 mL) 
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followed by a 1 h stir at room temperature. The mixture was concentrated under reduced 
pressure, taken up in ethyl acetate (15 mL), and washed with dilute sodium hydroxide (3 
x 10 mL, 2 M). The basic aqueous layer was acidified and extracted with 
dichloromethane (3 x 15 mL). The combined organic extracts were dried (anhyd. MgSO4) 
and concentrated under reduced pressure to afford the crude β,γ-unsaturated acid (320 
mg, 2.0mmol) which was used in the next step without further purification. 
Following the general amidation procedure with DCC, the crude β,γ-unsaturated 
acid affords, after flash chromatography on silica gel (80:20 hexanes:ethyl acetate), the 
title compound (390 mg, 60%) as a white solid: mp 90–92.5 ºC; TLC analysis Rf 0.40 
(75:25 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 7.87 (1H, br s, NH), 7.53 
(2H, d, J = 8.1 Hz, c,c’), 7.32 (2H, t, J = 8.1 Hz, b,b’), 7.11 (1H, t, J = 7.5 Hz, a), 5.09 
and 5.06 (2H, s’s, h), 3.13 (2H, s, f), 2.02 (2H, d, J = 6.9 Hz, i), 1.90–1.75 (1H, m, j), 
0.91 (6H, d, J = 6.6 Hz, k,k’); 13C NMR (75 MHz, CDCl3) δ 168.92 (e), 143.29(d), 
137.90 (g), 128.94 (b,b’), 124.30 (a), 119.84 (c,c’), 116.17 (h), 45.67 (f), 45.63 (j), 25.96 
(i), 22.41 (k,k’); IR (neat) 3290 (N-H stretch), 2953, 2921, 2865, 1657 (C=O stretch), 
1638, 1595, 1530 (N-H bend), 1440, 1393, 1307, 1295, 1251 (C-N stretch), 1223, 1162, 
1120, 996, 869, 738, 668, 617 cm-1; HRMS (CI) calcd. for C14H20NO (M+H): 218.1545, 
found 218.1539 m/z. 
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    Preparation 3-Methylidene-pentanoic acid phenyl amide (X17): Following the 
general procedure, 3-ethyl-3-butenoic acid tert-butyl ester X25 (511 mg, 3.0 mmol) 
affords, after flash chromatography on silica gel (75:25 hexanes:ethyl acetate), the title 
compound (362 mg, 64%, 2 steps) as a white solid: mp 101–102 ºC; TLC analysis Rf 0.40 
(75:25 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.62 (1H, br s, NH), 7.52 
(2H, d, J = 8.0 Hz, c,c’), 7.33 (2H, t, J = 7.6 Hz, b,b’), 7.12 (1H, t, J = 7.6 Hz, a), 5.11 
and 5.06 (2H, s’s, h), 3.17 (2H, s, f), 2.18 (2H, q, J = 7.2 Hz, i), 1.11 (3H, t, J = 7.2 Hz, 
j); 13C NMR (100 MHz, CDCl3) δ 168.72 (e), 146.09(d), 137.79 (g), 128.98 (b,b’), 
124.33 (a), 119.74 (c,c’), 113.92 (h), 46.23 (f), 28.89 (i), 12.12 (j); IR (neat) 3240 (N-H 
stretch), 3187, 2955, 2839, 1658 (C=O stretch), 1595, 1544 (N-H bend), 1488, 1444, 
1400, 1352, 1297, 1252 (C-N stretch), 1187, 969, 759, 693 cm-1; HRMS (CI) calcd. for 
C12H16NO (M+H): 190.1232, found 190.1237 m/z. 
 
    Preparation 3-Methylidene-6-phenylhexanoic acid phenyl amide (X22): Following 
the general procedure, tert-butyl ester X31 (781 mg, 3.0 mmol) affords, after flash 
chromatography on silica gel (80:20 hexanes:ethyl acetate), the title compound (476 mg, 
57%, 2 steps) as a white solid: mp 51–53 ºC; TLC analysis Rf 0.50 (75:25 hexanes:ethyl 
acetate); 1H NMR (400 MHz, CDCl3) δ 7.60 (1H, br s, NH), 7.52 (2H, d, J = 7.9 Hz, 
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m,m’), 7.40–7.35 (2H, m, c,c’), 7.35–7.25 (2H, m, b,b’), 7.25–7.20 (3H, m, n,n’,o), 7.15 
(1H, t, J = 7.3 Hz, a), 5.13 and 5.11 (2H, s’s, h), 3.18 (2H, s, f), 2.66 (2H, t, J = 7.7 Hz, 
k), 2.22 (2H, t, J = 7.4 Hz, i), 1.90–1.80 (2H, m, j); 13C NMR (100 MHz, CDCl3) δ 
168.71 (e), 144.20 (d), 141.98 (l), 137.71 (g), 129.02 (b,b’), 128.44 (m,m’), 128.37 (n,n’), 
125.87 (o), 124.43 (a), 119.83 (c,c’), 115.20 (h), 46.06 (f), 35.52 (i), 35.42 (k), 29.24 (j). 
Representative procedure for the preparation of β,γ-unsaturated tert-butyl esters 61 
 
  
    Preparation of 3-methyl-3-butenoic acid tert-butyl ester (X23): To a cooled (-78 
°C) solution of N,N-diisopropylamine (4.2 mL, 30 mmol) in THF (5 mL) was slowly 
added n-butyllithium (12 mL of a 2.5 M soln. in hexanes, 30 mmol). The resultant 
mixture was allowed to stir for 0.5 h at the same temperature before the dropwise 
addition of tert-butyl acetate (4.0 mL, 30 mmol). The reaction mixture was allowed to stir 
for an additional 0.5 h and the generated tert-butyl lithioacetate solution was used in the 
next step. 
 To a cooled (-78 °C) suspension of nickel bromide (2.76 g, 12.6 mmol) in THF 
(15 mL) was added n-butyllithium (2 mL of a 2.5 M soln. in hexanes, 5 mmol). After the 
resultant black mixture was allowed to stir for 15 min, 2-bromopropene (2.66 mL, 30 
mmol) was added followed by the tert-butyl lithioacetate solution prepared in the 
previous step. The reaction was allowed to slowly rise to room temperature and stirred 
for an additional 1 h. The reaction mixture was quenched by the addition of dilute HCl 
(15 mL, 1 M) and then extracted with diethylether (2 x 20 mL). The combined organic 
76 
 
 
extracts were dried (anhyd. MgSO4) and concentrated under reduced pressure. Flash 
chromatography over silica gel (80:20, hexanes:dichloromethane) affords the title 
compound (2.34 g, 50%) as a light yellow oil; TLC analysis Rf 0.50 (50:50 
hexanes:dichloromethane); 1H NMR (300 MHz, CDCl3) δ 4.88 and 4.82 (2H, s’s, f), 2.93 
(2H, s, d), 1.80 (3H, s, g), 1.45 (9H, s, a,a’,a”); 13C NMR (75 MHz, CDCl3) δ 170.72 (c), 
139.13 (e), 114.09 (f), 80.42 (b), 44.79 (d), 27.99 (a,a’,a”), 22.38 (g); IR (neat) 3075, 
2976, 2934, 1728 (C=O stretch), 1647, 1455, 1366, 1258 (C-O stretch), 1139, 690, 843 
cm-1. 
 
 
 Preparation of 3-Methylidenepentanoic acid tert-butyl ester (X25): Following 
the general procedure, 2-bromobutene (4.1 g, 30 mmol) affords, after flash 
chromatography on silica gel (80:20 hexanes:dichloromethane), the title compound (2.9 
g, 59%) as a light yellow oil: TLC analysis Rf 0.55 (50:50 hexanes:dichloromethane); 1H 
NMR (400 MHz, CDCl3) δ 4.91 and 4.88 (2H, s’s, f), 2.97 (2H, s, d), 2.12 (2H, q, J = 7.6 
Hz, g), 1.46 (9H, s, a,a’,a”), 1.06 (3H, t, J = 7.6 Hz, h); 13C NMR (100 MHz, CDCl3) δ 
170.99 (c), 144.65 (e), 111.83 (f), 80.40 (b), 43.47 (d), 28.78 (g), 28.01 (a,a’,a”), 12.02 
(h); IR (neat) 2935, 2848, 1731 (C=O stretch), 1653, 1391, 1252 (C-O stretch), 1145, 
1122, 1040, 948, 761, 576 cm-1. 
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      Preparation of 3-phenyl-3-butenoic acid tert-butyl ester (X27): Following the 
general procedure, (1-bromovinyl)benzene (4.36 g, 24 mmol) affords, after flash 
chromatography on silica gel (80:20 hexanes:dichloromethane), the title compound (2 g, 
38%) as a light yellow oil; TLC analysis Rf 0.50 (50:50 hexanes:dichloromethane);1H 
NMR (400 MHz, CDCl3) δ 7.40–7.30 (2H, m, j,j’), 7.30–7.20 (3H, m, i,i’, k), 5.01 and 
4.95 (2H, s’s, f), 3.48 (2H, s, g), 2.92 (2H, s, d), 1.49 (9H, s, a,a’,a”); 13C NMR (75 MHz, 
CDCl3) δ 170.60 (c), 141.71 (g), 140.16 (e), 128.29 (h,h’), 127.64 (i,i’), 125.94 (j), 
115.72 (f), 80.70 (b), 42.73 (d), 27.89 (a,a’,a”). 
 
    Preparation of 3-(2-phenylethyl)-3-butenoic acid tert-butyl ester (X28): Following 
the general procedure, 2-bromo-4-phenylbutene (4.13 g, 20 mmol) affords, after flash 
chromatography on silica gel (75:25 hexanes:dichloromethane), the title compound (2.03 
g, 42%) as a light yellow oil; TLC analysis Rf 0.60 (50:50 hexanes:dichloromethane); 1H 
NMR (300 MHz, CDCl3) δ 7.40–7.30 (2H, m, k,k’), 7.30–7.20 (3H, m, j,j’, l), 4.99 and 
4.97 (2H, s’s, f), 3.03 (2H, s, d), 2.83 (2H, t, J = 7.5 Hz, h), 2.46 (2H, t, J = 8.4 Hz, g), 
1.51 (9H, s, a,a’,a”); 13C NMR (75 MHz, CDCl3) δ 170.80 (c), 142.47 (i), 141.85 (e), 
128.35 (j,j’, k,k’), 125.88 (l), 113.64 (f), 80.58 (b), 43.49 (d), 37.72 (g), 34.05 (h), 28.08 
78 
 
 
(a,a’,a”); IR (neat) 3028, 2978, 2931, 1726 (C=O stretch), 1647, 1496, 1454, 1366, 1255 
(C-O stretch), 1139, 1030, 956, 896, 841, 744, 697 cm-1. 
 
Representative preparation of  of tert-butyl esters via of vinyl 62 
 
 
    Preparation of 3-iso-butyl-3-butenoic acid tert-butyl ester (X26): To a mixture of 
2,3-dibromopropene (7.01 g, 35 mmol) and copper chloride (173 mg, 1.8 mmol) in THF 
(30 mL) was slowly added isobutylmagnesium bromide (40 mmol, 13.8 mL of a 2.9 M 
solution in THF) at room temperature. After a 5 h stir, the reaction was quenched with 
satd. aq. ammonium chloride (30 mL) and then extracted with diethyl ether (3 x 30 mL). 
The combined organic extracts were dried (anhyd. MgSO4) and concentrated under 
reduced pressure. The crude residue was taken up in hexanes, passed through a short 
silica plug, and concentrated under reduced pressure. The resultant crude 2-bromo-4-
methylpentene (4.25 g, 26 mmol) was used in the next step without further purification. 
Following the general procedure for the nickel-catalyzed substitution of vinyl 
bromides, crude vinyl bromide prepared in the previous step affords, after flash 
chromatography on silica gel (70:30, hexanes:dichloromethane), the title compound (3.12 
g, 45%) as a light yellow oil: TLC analysis Rf 0.50 (50:50 hexanes:dichloromethane); 1H 
NMR (400 MHz, CDCl3) δ 4.91 and 4.87 (2H, s’s, f), 2.92 (2H, s, d), 1.98 (2H, d, J = 7.2 
Hz, g), 1.95–1.85 (1H, m, h), 1.46 (9H, s, a,a’,a”), 0.89 (6H, d, J = 6.6 Hz, i,i’); 13C NMR 
(100 MHz, CDCl3) δ 170.90 (c), 141.96 (e), 114.33 (f), 80.36 (b), 45.79 (d), 43.03 (g), 
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28.00 (a,a’,a”), 25.75 (h), 22.38 (i,i’); IR (neat) 2969, 2912, 1722 (C=O stretch), 1431, 
1376, 1177 (C-O stretch), 1117, 884, 826, 740, 521 cm-1. 
 
 
 Preparation of 3-Benzyl-3-butenoic acid tert-butyl ester (X24): Following the 
general procedure, crude 2-bromo-3-phenylpropene prepared from 2,3-dibromopropene 
(7.01 g, 35 mmol) and phenylmagnesium bromide (40 mmol, 40 mL of a 1.0 M solution 
in THF) affords, after flash chromatography on silica gel (80:20, 
hexanes:dichloromethane), the title compound (4.40 g, 54%) as a light yellow oil; TLC 
analysis Rf 0.60 (50:50 hexanes:dichloromethane); 1H NMR (300 MHz, CDCl3) δ 7.40–
7.30 (2H, m, j,j’), 7.30–7.20 (3H, m, i,i’,k), 5.01 and 4.95 (2H, s’s, f), 3.48 (2H, s, g), 
2.92 (2H, s, d), 1.49 (9H, s, a,a’,a”); 13C NMR (75 MHz, CDCl3) δ 170.75 (c), 142.43 (h), 
138.97 (e), 129.17 (i,i’), 128.39 (j,j’), 126.30 (k), 115.26 (f), 80.59 (b), 42.68 (g), 42.40 
(d), 28.06 (a,a’,a”); IR (neat) 2978, 1725 (C=O stretch), 1647, 1494, 1366, 1253(C-O 
stretch), 1137, 966, 898, 838, 728, 696, 628 cm-1. 
 
     Preparation 3-(3-phenylpropyl)-3-butenoic acid tert-butyl ester (X31): Following 
the general procedure, crude 2-bromo-5-phenylpentene prepared from 2,3-
80 
 
 
dibromopropene (4.02 g, 20 mmol) and 2-phenylethylmagnesiumbromide (15 mmol) 
affords, after flash chromatography on silica gel (75:25 hexanes:dichloromethane), the 
title compound (2.23 g, 57%) as a light yellow oil; TLC analysis Rf 0.60 (50:50 
hexanes:dichloromethane); 1H NMR (300 MHz, CDCl3) δ 7.35–7.25 (2H, m, l,l’), 7.25–
7.15 (3H, m, k,k’, m), 4.94 and 4.93 (2H, s’s, f), 2.97 (2H, s, d), 2.65 (2H, t, J = 7.6 Hz, 
i), 2.17 (2H, t, J = 7.5 Hz, g), 1.90–1.75 (2H, m, h), 1.46 (9H, s, a,a’,a”); 13C NMR (75 
MHz, CDCl3) δ 170.93 (c), 142.74 (j), 142.33 (e), 128.45 (k,k’), 128.31 (l,l’), 125.74 (m), 
113.30 (f), 80.54 (b), 43.35 (d), 35.50 (g), 35.47 (i), 29.14 (h), 28.03 (a,a’,a”); IR (neat) 
3026, 2933, 2863, 1726 (C=O stretch), 1645, 1496, 1366, 1255 (C-O stretch), 1140, 897, 
839, 744, 695 cm-1. 
 
Representative procedure for rhodium-catalyzed asymmetric hydroboration 
 
    Preparation of (3R)-4-Hydroxy-3-methylbutanoic acid phenyl amide (X(16)-1): A 
stock solution (2.0 mL) containing Rh(nbd)2BF4 (2.6 mM) and (3,5-dimethyl-
TADDOL)POPh (L, 5.6 mM) in THF was prepared. To the resulting yellow solution 
[Rh(nbd)2BF4 (2.0 mg, 0.0053 mmol) and (3,5-dimethyl-TADDOL)POPh (L2a, 7.8 mg, 
0.011 mmol)] was slowly added over the course of 15 min a solution of 1,1-disubstituted 
alkene X16 (92.45 mg, 0.528  mmol) in THF (2.0 mL). To the reaction mixture was 
slowly added a solution of 4,4,6-trimethyl-1,3,2-dioxaborinane (TMDB, 135 mg, 1.1 
mmol) in THF (1.0 mL) over the course of 0.5 h. After an additional 24 h stir, 
Afterwards, the reaction mixture was re-cooled (0 oC), diluted with THF (15 mL) and 
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quenched by the slow addition of methanol (6 mL) followed by the dropwise addition of 
3 N aq. NaOH (8 mL) and 30% H2O2 (1 mL), the resultant mixture was extracted with 
dichloromethane (2 x 10 mL). The combined organic extracts were dried (anhyd. MgSO4) 
and then concentrated under reduced pressure. Flash chromatography on silica gel (60:40 
hexanes:ethyl acetate) affords the title compound (52%, 95% ee) as a white solid: mp 
115–117 ºC; TLC analysis Rf 0.70 (50:50 hexanes:ethyl acetate); chiral HPLC analysis 
(Chiralcel-IC,  
 80:2 0 hexanes: isopropanol) showed peaks at 17 minutes (3% (R)) and 21 minutes (97 
% (S)); 1H NMR (300 MHz, CDCl3) δ 8.21 (1H, br s, OH), 7.51 (2H, d, J = 7.8 Hz, c,c’), 
7.30 (2H, t, J = 7.6 Hz, b,b’), 7.10 (1H, t, J = 7.4 Hz, a), 3.70–3.55 (1H, m, h), 3.55–3.40 
(2H, m, h, OH), 2.52 and 2.29 (2H, overlapping dd’s, J1 = 14.0 Hz, 6.8 Hz, J2 = 14.0 Hz, 
6.00 Hz, f), 2.30–2.20 (1H, m, g), 1.00 (3H, d, J = 6.7 Hz, i); 13C NMR (75 MHz, CDCl3) 
δ 171.71 (e), 137.88 (d), 128.94 (b,b’), 124.40 (a), 120.19 (c,c’), 67.46 (h), 42.16 (f), 
33.36 (g), 17.03 (i); HRMS (CI) calcd. for C11H16NO2 (M+H): 194.1181, found 194.1180 
m/z. 
 
 
    Preparation of (3R)-3-Ethyl-4-hydroxybutanoic acid phenyl amide (X(17)-1): 
Following the general procedure, 1,1-disubstituted alkene X17 (99.85 mg, 0.528  mmol) 
affords, after flash chromatography on silica gel (60:40 hexanes:ethyl acetate), the title 
compound (65.61 mg, 60%) as a white solid: mp 118–119.5 ºC; TLC analysis Rf 0.50 
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(50:50 hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 90:10 
hexanes:isopropanol) showed peaks at 37 minutes (5.0% (R)) and 45 minutes (95.0% 
(S)); 1H NMR (400 MHz, CDCl3) δ 7.83 (1H, br s, NH), 7.52 (2H, d, J = 7.9 Hz, c,c’), 
7.33 (2H, t, J = 7.8 Hz, b,b’), 7.12 (1H, t, J = 7.3 Hz, a), 3.78 (1H, dd, J1 = 10.5 Hz, J2 = 
3.0 Hz, h), 3.59 (1H, dd, J1 = 10.5 Hz, J2 = 6.8 Hz, h), 2.87 (1H, br s, OH), 2.55–2.45 
(2H, m, f), 2.10–2.00 (1H, g), 1.50–1.35 (2H, m, i), 0.98 (3H, t, J = 7.4 Hz, j); 13C NMR 
(100 MHz, CDCl3) δ 171.63 (e), 137.83 (d), 128.99 (c,c’), 124.38 (a), 119.99 (b,b’), 
65.32 (h), 40.46 (f), 39.75 (g), 24.36 (i), 11.59 (j). 
 
 
    Preparation of (3R)-3-iso-butyl-4-hydroxybutanoic acid phenyl amide (X(18)-1): 
Following the general procedure, 1,1-disubstituted alkene X18 (114.65mg, 0.528  mmol) 
affords, after flash chromatography on silica gel (80:40 hexanes:ethyl acetate), the title 
compound (89.39 mg, 72%) as a white solid: mp 92–94 ºC; TLC analysis Rf 0.60 (50:50 
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 90:10 hexanes:isopropanol) 
showed peaks at 26 minutes (2.0% (R)) and 29 minutes (96.0% (S)); 1H NMR (300 MHz, 
CDCl3) δ 7.88 (1H, br s, NH), 7.50 (2H, d, J = 7.9 Hz, c,c’), 7.32 (2H, t, J = 7.8 Hz, b,b’), 
7.12 (1H, t, J = 7.3 Hz, a), 3.79 (1H, dd, J1 = 10.5 Hz, J2 = 3.0 Hz, h), 3.57 (1H, dd, J1 = 
10.5 Hz, J2 = 6.8 Hz, h), 2.87 (1H, br s, OH), 2.55–2.45 (2H, m, f), 2.20–2.10 (1H, g), 
1.69–1.66(1H, m, j), 1.28-1,22 (2H, m, i), 0,91 (6H, d, J = 3 Hz,  k,k’); 13C NMR (75 
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MHz, CDCl3) δ 171.61 (e), 137.84 (d), 128.97 (c,c’), 124.36 (a), 120,01 (b,b’), 65.76 (h), 
40.90 (f), 40.72 (g), 35.78(j), 25,72(i), 22,78-22,66 (k,k’). 
 
     
Preparation of (3S)-3-cyclohexyl-4-hydroxybutanoic acid phenyl amide (X(19)-1): 
Following the general procedure, 1,1-disubstituted alkene X19 (128.38 mg, 0.528  mmol) 
affords, after flash chromatography on silica gel (60:40 hexanes:ethyl acetate), the title 
compound (99.28 mg, 72%) as a white solid: mp 88–89 ºC; TLC analysis Rf  0.60 (60:40 
hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 90:10 hexanes:isopropanol) 
showed peaks at 42 minutes (4.0% (R)) and 46 minutes (94.0% (S)); 1H NMR (300 MHz, 
CDCl3) δ 7.71 (1H, br s, NH), 7.50 (2H, d, J = 7.9 Hz, c,c’), 7.33 (2H, t, J = 7.8 Hz, b,b’), 
7.12 (1H, t, J = 7.3 Hz, a), 3.79 (1H, m,  h), 3.68 (1H, m, h), 2.69 (1H, br s, OH), 2.55–
2.45 (2H, d, J=6.3, f), 2.00–1.93 (1H, m,  g),  1.75-1.60 (5H, m, i ,j,j’), 1.55–1.12(6H, m,  
k,k’ , l); 13C NMR (75 MHz, CDCl3) δ 171.61 (e), 137.84 (d), 128.97 (c,c’), 124.36 (a), 
120,01 (b,b’), 64.44 (h), 43.38 (f), 39.55 (g), 38,88(i), 30.37(j,j’), 26.54,(k,k’), 26,84(l). 
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    Preparation of (3S)-4-Hydroxy-3-phenylbutanoic acid phenyl amide (X(20)-1): 
Following the general procedure, 1,1-disubstituted alkene X20 (125.19 mg, 0.528 mmol) 
affords, after flash chromatography on silica gel (60:40 hexanes:ethyl acetate), the title 
compound (95.64 mg, 71%) as a white solid: mp 95.5–97 ºC; TLC analysis Rf 0.50 
(50:50 hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 80:20 
hexanes:isopropanol) showed peaks at 20 minutes (2.0% (R)) and 24 minutes (95.0% 
(S)); 1H NMR (300 MHz, DMSO-d6) δ 9.86 (1H, br s, NH), 7.51 (2H, d, J = 8.0 Hz, 
c,c’), 7.30–7.10 (7H, m, b,b’,j,j’, k,k’, l), 6.98 (1H, t, J = 7.3 Hz, a), 4.79 (1H, t, J = 5.2 
Hz, OH), 3.65–3.50 (2H, m, h), 3.35–3.20 (1H, m, g), 2.82 and 2.60 (2H, overlapping 
dd’s, J1 = 14.8 Hz, 5.9 Hz, J2 = 14.8 Hz, 8.9 Hz, f); 13C NMR (75 MHz, DMSO-d6) δ 
170.55 (e), 143.16 (d), 139.67 (i), 129.06 (j,j’), 128.55 (b,b’), 128.32 (k,k’), 126.64 (l), 
123.40 (a), 119.45 (c,c’), 65.84 (h), 44.92(f). 
 
    Preparation of (3R)-4-Hydroxy-3-(2-phenylethyl)butanoic acid phenyl amide 
(X(21)-1): Following the general procedure, 1,1-disubstituted alkene X21 (139.99 mg, 
0.528 mmol) affords, after flash chromatography on silica gel (60:40 hexanes:ethyl 
acetate), the title compound (109.14 mg, 73%) as a white solid: mp 81–83 ºC; TLC 
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analysis Rf 0.50 (60:40 hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 90:10 
hexanes:isopropanol) showed peaks at 40 minutes (2.0% (R)) and 46 minutes (95.0% 
(S)); 1H NMR (400 MHz, CDCl3) δ 7.75 (1H, br s, NH), 7.50 (2H, d, J = 7.8 Hz, c,c’), 
7.35–7.25 (4H, m, b,b’, l,l’), 7.25–7.15 (3H, m, m,m’, n), 7.13 (1H, t, J = 7.4 Hz, a), 
3.85–3.75 (1H, m, h), 3.70–3.60 (1H, m, h), 2.92 (1H, br s, OH), 2.80–2.65 (2H, m, j), 
2.55–2.45 (2H, m, f), 2.20–2.10 (1H, m, g), 1.80–1.65 (2H, m, i); 13C NMR (100 MHz, 
CDCl3) δ 171.32 (e), 141.89 (k), 137.75 (d), 129.01 (l,l’), 128.48 (b,b’), 128.37 (m,m’), 
125.98 (n), 124.44 (a), 120.02 (c,c’), 65.36 (h), 40.60 (f), 37.77 (j), 33.41 (g), 33.11 (i); 
IR (neat) 1677 (C=O stretch), 1040, 1122(C-O stretch), 3200(OH stretch), 1399, 1439, 
1409(C-N stretch), 675, 829, 638 cm-1; HRMS (CI) calcd. for C18H22NO2 (M+H): 
284.1651, found 284.1656 m/z. 
 
 
    Preparation of (3R)-3-Hydroxymethyl-6-phenylhexanoic acid phenyl amide 
(X(22)-1): Following the general procedure, 1,1-disubstituted alkene X22 (147.39 mg, 
0.528 mmol) affords, after flash chromatography on silica gel (60:40 hexanes:ethyl 
acetate), the title compound (109.83 mg, 70%) as a white solid: mp 78.5–80 ºC; TLC 
analysis Rf 0.50 (50:50 hexanes:ethyl acetate); Chiral HPLC analysis (Chiralcel-IC, 90:10 
hexanes:isopropanol) showed peaks at 26 minutes (2.0% (R)) and 31 minutes (94.0% 
(S)); 1H NMR (400 MHz, CDCl3) δ 7.76 (1H, br s, NH), 7.51 (2H, d, J = 7.8 Hz, c,c’), 
7.33–7.29 (4H, m, b,b’, m,m’), 7.23–7.17 (3H, m, n,n’, o), 7.13 (1H, t, J = 7.4 Hz, a), 
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3.75 (1H, m, h), 3.58 (1H, m, h),  2.65 (2H, m, k), 2.55–2.45 (2H, m, f), 2.20–2.10 (1H, 
m, g), 1.71-1.51(2H, m, i), 1.51–1.45 (2H, m,  j); 13C NMR (100 MHz, CDCl3) δ 171.21 
(e), 141.89 (i), 137.75 (d), 129.01 (m,m’), 128.48 (b,b’), 128.37 (n.n’), 125.98 (o), 124.44 
(a), 120.02 (c,c’), 65.36 (h), 40.10 (f), 38.04 (k), 32.60 (g), 31.08 (i), 20.06 (j). 
 
Representative procedure for preparation lactones 57 
 
 
    Preparation of (4S)-4-isobutylbutyrolactone (X(26)-1): 1,1-disubstituted alkene X26 
(102 mg, 0.528 mmol) was subjected to standard CAHB conditions . The resultant 
reaction mixture was diluted with an additional 10 mL of THF followed by slow addition 
of NaOH (6 mL of a 3 M aqueous soln.) and dropwise addition of H2O2 (0.6 mL of a 30% 
aqueous soln.). After a 2 h stir, sodium metabisulfite (Na2SO5, 4 mL of a 10% aqueous 
soln.) was added and the resultant mixture was acidified (6 M HCl) and extracted with 
dichloromethane (3 x 10 mL). The combined organic extracts were dried (anhyd. MgSO4) 
and concentrated under reduced pressure. Flash chromatography on silica gel (75:25 
hexanes:ethyl acetate) affords the title compound (58.6 mg, 78%) as a light yellow oil; 
TLC analysis Rf 0.50 (75:25 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 4.41 
(1H, dd, J1 = 8.8 Hz, J2 = 8.1 Hz, d), 3.88 (1H, dd, J1 = 8.9 Hz, J2 = 8.6 Hz, d), 2.70–2.55 
(2H, m, b), 2.25–2.10 (1H, m, c), 1.65–1.50 (1H, m, f), 1.36 (2H, t, J = 7.1 Hz, e), 0.93 
(3H, t, J = 6.6 Hz, g), 0.90 (3H, t, J = 6.6 Hz, g’); 13C NMR (100 MHz, CDCl3) δ 177.22 
(a), 73.56 (d), 42.21 (e), 34.76 (b), 33.83 (c), 26.28 (f), 22.64 (g), 22.40 (g’); IR (neat) 
87 
 
 
2956, 2903, 1773 (C=O stretch), 1469, 1420, 1367, 1216, 1168 (C-O stretch), 1011, 913, 
838, 730, 646, 557 cm-1. 
 
    Preparation of (3R)-4-benzylbutyrolactone (X(24)-1):63Following the general 
procedure, 1,1-disubstituted alkene X24 (123 mg, 0.528 mmol) affords, after flash 
chromatography on silica gel (75:25 hexanes:ethyl acetate), the title compound (73.2 mg, 
80%) as a light yellow oil; TLC analysis Rf 0.40 (75:25 hexanes:ethyl acetate); 1H NMR 
(400 MHz, CDCl3) δ 7.34 (2H, t, J = 7.2 Hz, h,h’), 7.27 (1H, d, J = 6.9 Hz, i), 7.17 (2H, 
d, J = 7.3 Hz, g,g’), 4.35 (1H, dd, J1 = 8.9 Hz, J2 = 8.9 Hz, d), 4.05 (1H, dd, J1 = 6.2 Hz, 
J2 = 6.1 Hz, d), 2.95–2.85 (1H, m, c), 2.85–2.75 (2H, m, e), 2.62 (1H, dd, J1 = 17.4 Hz, J2 
= 7.9 Hz, b), 2.31 (1H, dd, J1 = 17.4 Hz, J2 = 6.9 Hz, b); 13C NMR (100 MHz, CDCl3) δ 
176.84 (a), 138.25 (f), 128.81 (g,g’), 128.67 (h,h’), 126.83 (i), 72.66 (d), 38.95 (e), 37.18 
(b), 34.25 (c); IR (neat) 2963, 2909, 1773 (C=O stretch), 1496, 1417, 1257, 1166 (C-O 
stretch), 1088, 1012, 910, 797, 731, 699, 638, 531 cm-1. 
 
 
    Preparation of (3R)-4-methylbutyrolactone (X(23)-1): Following the general 
procedure, 1,1-disubstituted alkene X23 (82.43 mg, 0.528 mmol) affords, after flash 
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chromatography on silica gel (75:25 hexanes:ethyl acetate), the title compound (32.75 
mg, 62%) as a light yellow oil; TLC analysis Rf 0.60 (80:20 hexanes:ethyl acetate);1H 
NMR (400 MHz, CDCl3) δ 4.41 (1H, dd, J1 = 8.0 Hz, J2 = 8.1 Hz, d), 3.87 (1H, dd, J1 = 
8.0Hz, J2 = 8.6 Hz, d), 2.68–2.65 (2H, m, b), 2.17–2.15(1H, m, c), 1.17 (3H, d, J = 6.4 
Hz, e); 13C NMR (100 MHz, CDCl3) δ 177.21 (a), 74.68 (d), 34.14 (b), 30.40 (c), 17.94 
(e). 
 
 
    Preparation of (3R)-4-(phenylethyl)butyrolactone (X(28)-1): Following the general 
procedure, 1,1-disubstituted alkene X28 (139.47 mg, 0.528 mmol) affords, after flash 
chromatography on silica gel (75:25 hexanes:ethyl acetate), the title compound (61.27 
mg, 61%) as a light yellow oil; TLC analysis Rf 0.40 (75:25 hexanes:ethyl acetate); 1H 
NMR (400 MHz, CDCl3) δ 7.33(2H, J= 7.2 Hz, i,i’), 7.26 (1H, d, J=7.0Hz, j),7.17 (2H, d, 
J=7.3 Hz, h,h’) , 4.44 (1H, dd, J1 = 9.0 Hz, J2 = 8.0 Hz, d), 3.97 (1H, dd, J1 = 9.0 Hz, J2 = 
7.0 Hz, d), 2.85–2.74 (2H, m, f), 2.75–2.53 (2H, m, b), 2.30–2.19 (1H, m, c), 1.89–1.74 
(2H, m, e); 13C NMR (100 MHz, CDCl3) δ 177.06 (a), 138.23 (g), 128.80 (h,h), 128.67 
(i,i’), 126.83 (j), 73.21 (d), 35.27 (e), 34.46 (b), 33.24 (f), 31.48 (c). 
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Representative procedure for preparation of γ-borylated product 
 
    Preparation of (3R)-tert-butyl-3-((4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)methyl) 
pentanoate: Following the representative procedure for rhodium-catalyzed asymmetric 
hydroboration of β,γ-unsaturated amides at room temperature, hydroboration of β,γ-
unsaturated ester T3 (89.8 mg, 0.528 mmol) affords, after flash chromatography on silica 
gel (95:5 hexanes:ethyl acetate), the title compound (102.35 mg, 65 %) as a yellow oil; 
TLC analysis Rf  0.60 (70:30 hexanes:ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 4.22-
4.11 (1H, m, j), 2.20-2.17 (2H, dd, J = 6.9 Hz, d), 2.04-1.95 (1H, m, e), 1.79-1.74 (1H, 
dd, J = 13.8 Hz, i), 1.50-1.41 (1H, m, i),1.46 (9H, s, a,a’,a’’), 1.40-1.32 (2H, m, l), 1.28 
(6H, s, h,h’), 1.24 (3H, d, J = 6.2 Hz, k), 0.88 (3H, t, J = 7.4 Hz, m), 0.69 (2H, d, J = 6.8 
Hz, f); 13C NMR (75 MHz, CDCl3) δ 173.24 (c), 79.51 (b), 70.39 (g), 64.41 (j), 45.96 (i), 
42.33 (d), 33.27 (e), 31.28 (h, h’), 28.94 (l), 28.16 (a,a’,a’’), 28.06 (f), 23.21 (k), 11.19 
(m). 
 
Representative procedure preparation of alcohol via oxidation with NaBO3. 
 
Preparation of (3R)-tert-butyl-3-(hydroxymethyl)-5-methylhexanoate (X(26)-
1): Following the general procedure for the CAHB of 1,1-disubstituted alkene X26, the 
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resultant reaction mixture was concentrated under reduced pressure and then taken up in 
THF (1.5 mL) and H2O (1.5 mL). NaBO3-tetrahydrate (40 mg, 0.26 mmol) was added to 
the resulting mixture. After a 2 h vigorous stir, the reaction was diluted with H2O (3 mL) 
and diethylether (4 mL). The aqueous layer was extracted with diethylether (2 x 3 mL) 
and the combined organic extracts were dried (anhyd. MgSO4) and concentrated under 
reduced pressure. The crude residue was purified via flash chromatography on silica gel 
(80:20 hexanes:dichloromethane) to afford the title compound (86.74 mg, 76%) as a light 
yellow oil; TLC analysis Rf 0.50 (60:40 hexanes:ethyl acetate);  1H NMR (300 MHz, 
CDCl3) δ 3.70–3.60 (1H, m, f), 3.60–3.40 (1H, m, f), 2.28 (2H, dd, J1 = 4.4 Hz, J2 = 2.5 
Hz, d), 2.16 (1H, br s, OH), 2.10–2.00 (1H, m, e), 1.70–1.60 (1H, m, h), 1.47 (9H, s, 
a,a’,a”), 1.30–1.20 (2H, m, g), 0.92 (3H, d, J = 4.7 Hz, i), 0.90 (3H, d, J = 4.7 Hz, i’); 13C 
NMR (75 MHz, CDCl3) δ 173.32 (c), 80.62 (b), 66.07 (f), 40.43 (g), 38.46 (d), 35.71 (e), 
28.08 (a,a’,a”), 25.19 (h), 22.80 (i), 22.67 (i’). 
 
 
    Preparation of tert-butyl 4-hydroxy-3-phenylbutanoate (X(27)-1):  Following the 
general procedure for the CAHB of 1,1-disubstituted alkene X27, the resultant reaction 
mixture was concentrated under reduced pressure and then taken up in THF (1.5 mL) and 
H2O (1.5 mL). NaBO3-tetrahydrate (40 mg, 0.26 mmol) was added to the resulting 
mixture. After a 2 h vigorous stir, the reaction was diluted with H2O (3 mL) and 
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diethylether (4 mL). The aqueous layer was extracted with diethylether (2 x 3 mL) and 
the combined organic extracts were dried (anhyd. MgSO4) and concentrated under 
reduced pressure. The crude residue was purified via flash chromatography on silica gel 
(80:20 hexanes:dichloromethane) to afford the title compound (78.54 mg, 63%) as a light 
yellow oil: TLC analysis Rf 0.70 (75:25 hexanes:ethyl acetate); 1H NMR (400 MHz, 
CDCl3) δ 7.39–7.31 (3H, m, i,i’,j), 7.25 (2H, d, J=8, h,h’), 3.84-3.70 (2H, m, f), 3.33 (1H, 
m, e), 2.73 and 2.60 (2H, m, d), 1.39 (9H, s, a,a’,a”); 13C NMR (75 MHz, CDCl3) δ 
171.92 (c), 141.12 (g), 128.61 (h,h’), 127.88 (i,i’), 126.70 (j), 80.66 (b), 67.03 (f), 41.10 
(d), 38.66(e), 27.93 (a,a’,a’’). 
 
General procedures for the preparation of L2a  
 
Preparation of (3,5-dimethyl-TADDOL)POPh (L2a): 3,5-Dimethyl-TADDOL 
was prepared as previously described64. To a cooled solution (dry ice-acetone bath, -78 
oC) of 3,5-imethyl-TADDOL (500 mg, 0.864 mmol) and triethylamine (TEA, 0.30 mL, 
2.16 mmol) in dry, oxygen-free THF (35 mL) was added PCl3 (0.07 mL, 0.86 mmol) in 
one portion. The resulting mixture was allowed to slowly warm to room temperature and 
stir over a total of ca. 12 h. Afterwards, the reaction mixture was filtered and the volatiles 
were removed on a vacuum line. The residue was dissolved in THF (5 mL) and the 
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resulting solution added (rapid addition) to a mixture of phenol (105.7 mg, 1.123 mmol) 
and TEA (0.18 mL, 1.3 mmol) in THF (35 mL). The resulting mixture was allowed to stir 
at room temperature for ca. 12 h. The resulting mixture was filtered and the volatiles 
were removed on a vacuum line. Flash chromatography on silica gel (97:3 hexanes:ethyl 
acetate) affords the title compound (412.0 mg, 68%) as a white foamy solid: mp 97.0-
98.2 oC; TLC analysis Rf 0.80 (95:5 hexanes: ethyl acetate); [α]D20 = -120.0o (c 0.5, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.35-7.20 (6H, m), 7.15-7.05 (5H, m), 6.99 (2H, 
d, J = 10.5 Hz), 6.90 (2H, s), 6.86 (2H, d, J = 7.6 Hz), 5.33 (1H, d, J  = 8.2 Hz), 5.17 (1H, 
d, J = 8.2 Hz), 2.40 (6H, s), 2.37 (6H, s), 2.32 (6H, s), 2.92 (6H, s), 0.99 (3H, s), 0.74 
(3H, s); 13C NMR (100 MHz, CDCl3) δ 152.16 (JCP = 2.9 Hz), 146.10 (JCP = 2.0 Hz), 
145.83, 141.23 (3.0 Hz), 141.02, 137.37, 136.99, 136.50, 136.29, 129.45, 129.07, 128.94, 
128.78, 126.89, 126.84, 125.10, 125.08, 123.33, 120.89, 120.81, 112.65, 85.51 (JCP = 8.1 
Hz), 84.64 (JCP = 4.2 Hz), 82.34 (JCP = 13.8 Hz), 81.28 (JCP = 4.8 Hz), 26.95, 26.48, 
21.69, 21.59, 21.48 (overlapping peaks); 31P NMR (162 MHz, CDCl3) δ 129.36; IR (neat) 
2916, 2863 (P-O stretching), 1595, 1489, 1455, 1370, 1213 (C-O-C stretch), 1159, 1035, 
939, 853, 800, 761, 689 cm-1; HRMS (FAB) calcd. for C45H49O5P (M+H): 701.3396, 
found 701.3409 m/z. 
 
Preparation of 4,4,6-Trimethyl-1,3,2-dioxaborinane ((TMD)BH):To a cooled 
(0 °C) solution of 2-methyl-2,4-pentanediol (1.54 g, 12 mmol) in dichloromethane (6 
mL) was slowly added borane (BH3, 1 mL of a 10 M solution in dimethylsulfide, 10 
mmol) dropwise. After the resulting mixture was stirred for 1.5 h at the same 
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temperature, the ice bath was removed and the reaction was allowed to stir for an 
additional 0.5 h. Volatiles were carefully removed under reduced pressure (i.e., 
concentration via rotovap while the mixture was submerged in a room temperature water 
bath). After complete removal of dichloromethane and dimethylsulfide (SMe2), the 
residue was purified via bulb-to-bulb distillation (160–165 °C) to afford the title 
compound (960 mg, 75%) as a colorless liquid: 1H NMR (300 MHz, CDCl3) δ 4.30–4.15 
(1H, m, d), 3.84 (1H, q, J = 155.6 Hz, BH), 1.90–1.75 (1H, m, c), 1.60–1.45 (1H, m, c), 
1.31 (3H, s, a), 1.29 (3H, s, a'), 1.26 (3H, d, J = 6.2 Hz, e); 13C NMR (75 MHz, CDCl3) δ 
70.99 (b), 64.73 (d), 46.17 (c), 31.02 (a), 28.14 (a'), 22.93 (e); 11B NMR (193 MHz, THF 
with residual CDCl3) δ 24.96 (d, J = 169.1 Hz); IR (neat) 2976 (CH sp3 stretch), 2879, 
2400, 1495, 1427, 1384, 1291, 1156 (C-O stretch), 1094, 1024, 889, 789, 666 cm-1; 
HRMS (CI) calcd. for C6H14BO2 (M+H): 129.1087, found 129.1082 m/z. 
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NAME     mob-082311-methyl acid
EXPNO                 1
PROCNO                1
Date_          20110823
Time              18.21
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    4
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 25.4
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -2.30 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
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NAME     mob-082311-methyl acid 13 c
EXPNO                 1
PROCNO                1
Date_          20110823
Time              19.13
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  617
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X1 
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NAME     mob-090111-phenyl ethyl alcohole
EXPNO                 1
PROCNO                1
Date_          20110901
Time              16.37
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 28.5
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -2.30 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
1H NMR X2 
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NAME     mob-080111- phenyl ethyl acohol
EXPNO                 1
PROCNO                1
Date_          20110801
Time              18.38
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  783
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X2 
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NAME     mob-090111-phenyl ethyl carbonate
EXPNO                 1
PROCNO                1
Date_          20110901
Time              22.53
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                   16
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 25.4
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -2.30 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
1H NMR X5 
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NAME     mob-090111-phenyl ethyl carbonate 13c
EXPNO                 1
PROCNO                1
Date_          20110901
Time              23.19
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  381
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X5 
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NAME     mob-082311-phenyl propyl ester
EXPNO                 1
PROCNO                1
Date_          20110822
Time              18.51
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    6
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                  181
DW               83.400 usec
DE                 6.50 usec
TE                673.2 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                15.00 usec
PL1               -4.40 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton
1H NMR X8 
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NAME     mob-82211-phenyl ethyl ester
EXPNO                 1
PROCNO                1
Date_          20110822
Time              19.31
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                  671
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG                16384
DW               27.800 usec
DE                 6.50 usec
TE                673.2 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.00 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.40 dB
PL12               8.98 dB
PL13               8.98 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677490 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X8 
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NAME     mob-080311-phenyl ethyl acid
EXPNO                 1
PROCNO                1
Date_          20110803
Time              13.33
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    4
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                 71.8
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -2.30 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
1H NMR X9 
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NAME     mob-080311-phenyl ethyl acid 13c
EXPNO                 1
PROCNO                1
Date_          20110803
Time              14.52
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  600
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1290.2
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X9 
1
0
8
 
  
    
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
1
.
8
7
8
1
.
8
8
1
3
.
1
5
0
5
.
0
3
0
5
.
0
9
5
5
.
1
0
0
7
.
1
0
1
7
.
1
0
4
7
.
1
2
9
7
.
1
5
0
7
.
1
5
4
7
.
2
7
5
7
.
2
8
2
7
.
3
0
6
7
.
3
1
3
7
.
3
4
1
7
.
3
5
9
7
.
3
6
6
7
.
5
1
7
3
.
0
6
2
.
0
8
1
.
0
4
1
.
0
0
1
.
0
0
2
.
0
4
3
.
0
0
NAME         mob-111111
EXPNO                 1
PROCNO                1
Date_          20110829
Time              10.59
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    8
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                  362
DW               83.400 usec
DE                 6.50 usec
TE                673.2 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                15.00 usec
PL1               -4.40 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton
1H NMR X16 
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NAME     mob-111111 13c
EXPNO                 1
PROCNO                1
Date_          20110829
Time              11.44
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                  896
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG              11585.2
DW               27.800 usec
DE                 6.50 usec
TE                673.2 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.00 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -4.40 dB
PL12               8.98 dB
PL13               8.98 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677490 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X16 
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NAME     mob-081611-methyl phenyl alcohole
EXPNO                 1
PROCNO                1
Date_          20110816
Time              17.04
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    4
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                12.00 usec
PL1               -2.30 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
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NAME     mob-081611-methyl phenyl alcohole 13c
EXPNO                 1
PROCNO                1
Date_          20110816
Time              18.00
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  749
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X(16)-1 
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NAME       mob-062612-3
EXPNO                 1
PROCNO                1
Date_          20120626
Time              10.59
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    5
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                322.5
DW               83.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1                2.20 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton
1H NMR X(17)-1 
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NAME     mob-062612-3  13 c
EXPNO                 1
PROCNO                1
Date_          20120626
Time              11.04
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                  507
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG              11585.2
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677490 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X(17)-1 
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NAME     mob-091911-phenyl ethyl alcohol
EXPNO                 1
PROCNO                1
Date_          20110919
Time              13.40
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                65536
SOLVENT           CDCl3
NS                    4
DS                    2
SWH            8278.146 Hz
FIDRES         0.126314 Hz
AQ            3.9584243 sec
RG                  362
DW               60.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1               -4.00 dB
SFO1        400.1324710 MHz
SI                32768
SF          400.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton NMR
1H NMR X(21)-1 
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NAME     mob-081711-phenyl ethyl amide
EXPNO                 1
PROCNO                1
Date_          20110817
Time              12.54
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                65536
SOLVENT           CDCl3
NS                  947
DS                    4
SWH           23980.814 Hz
FIDRES         0.365918 Hz
AQ            1.3664756 sec
RG               1625.5
DW               20.850 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                0.50 dB
SFO1        100.6228298 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2               -3.35 dB
PL12              13.34 dB
PL13              13.34 dB
SFO2        400.1316005 MHz
SI                32768
SF          100.6127690 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X(21)-1 
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NAME       mob-062612-6
EXPNO                 1
PROCNO                1
Date_          20120626
Time              12.12
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    4
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                 90.5
DW               83.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1                2.20 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton
1H NMR X(26)-1 
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NAME     mob-062612- 6  13 c
EXPNO                 1
PROCNO                1
Date_          20120626
Time              12.15
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                   63
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG                16384
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677490 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR  X(26)-1 
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NAME       mob-062612-2
EXPNO                 1
PROCNO                1
Date_          20120626
Time              10.39
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    5
DS                    2
SWH            5995.204 Hz
FIDRES         0.182959 Hz
AQ            2.7329011 sec
RG                  114
DW               83.400 usec
DE                 6.50 usec
TE                298.0 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                10.00 usec
PL1                2.20 dB
SFO1        300.1318534 MHz
SI                32768
SF          300.1300000 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0
PC                 1.00
1D Proton
1H NMR X(24)-1 
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NAME     mob-062612-2 13 c
EXPNO                 1
PROCNO                1
Date_          20120626
Time              10.54
INSTRUM           spect
PROBHD   5 mm QNP 1H/13
PULPROG          zgpg30
TD                32768
SOLVENT           CDCl3
NS                   24
DS                    4
SWH           17985.611 Hz
FIDRES         0.548877 Hz
AQ            0.9110004 sec
RG              11585.2
DW               27.800 usec
DE                 6.50 usec
TE                298.0 K
D1           2.00000000 sec
D11          0.03000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                13C
P1                10.00 usec
PL1                5.20 dB
SFO1         75.4752953 MHz
======== CHANNEL f2 ========
CPDPRG2         waltz16
NUC2                 1H
PCPD2             70.00 usec
PL2                2.20 dB
PL12              19.10 dB
PL13              19.10 dB
SFO2        300.1312005 MHz
SI                32768
SF           75.4677490 MHz
WDW                  EM
SSB                   0
LB                 1.00 Hz
GB                    0
PC                 1.40
13C
13C NMR X(24)-1 
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